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Abstract
The uterine environment in which a fetus grows and develops is now recognised as
a risk factor for the development of adult diseases such as cardiovascular disease
(CVD). A fetus relies on the nutrients and conditions delivered via the placenta, and
as such the placenta plays a vital role in the establishment and maintenance of
appropriate uterine conditions. Unfavourable uterine conditions such as an
inadequate resource flow from the placenta can lead to diminished growth of the
fetus and may ultimately result in both short and long-term increases in risk of CVD
for the baby. This has been demonstrated in large observational cohort studies and
has been corroborated in animal experiments. Despite these findings, there remains
significant variability in the association between the fetal environment and adult
disease risk in observational data across human populations. Moreover, the size of
the association between the placenta, as master of the uterine environment, and
CVD is yet to be quantified. In order to bridge this knowledge gap, the present study
conducted a systematic literature search and meta-analysis of published data
examining the effects of the placenta on cardiovascular outcomes across the life
course.
A systematic search was carried out and results were collated and assessed, with
records which met the selection criteria then entered in to a meta-analytical process
which included a funnel plot, calculation of Egger’s Regression Intercept and
estimation of effect size. The results of the search indicated that the association
between placental weight and CVD risk had been investigated in a total of 109,721
participants across eight countries. The meta-analytical process initially indicated
that higher blood pressure was related to a lighter placenta. On further inspection of
the funnel plot, a distinct outlier was detected. This outlier was removed and the
remaining records were analysed again. This second analysis indicated that higher
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blood pressure was related to a heavier placenta. This process demonstrated that a
single large study can substantially alter the results of a meta-analysis. Further, the
variety of confounding variables which a study can adjust for demonstrates that
placental weight cannot be viewed in isolation. None of the placenta studies relating
placental weight to cardiovascular outcomes (such as mortality and morbidity) were
comparable in this meta-analysis, indicating that there needs to be some guide to
uniformity in the data collection and analysis. Such a guide would lead to better
reporting and comparability between studies enabling new knowledge to build on
previous research in this field. Ultimately, improved comparability of these studies,
along with the transition of this field towards more complex measures of the placenta
such as thickness, circumference and volume as well as the use of real-time imaging
of the placenta, as the fetus develops in-utero, will contribute another dimension to
our understanding of the relationship between placental function and adult disease
risk.
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1. Introduction.
Cardiovascular Disease (CVD) is a major chronic, non-communicable disease and in
2015 the World Health Organisation (WHO) reported that CVD accounted for 31% of
all global deaths and 45% of deaths caused by non-communicable diseases (WHO,
2017). The burden of CVD is seen not only in mortality rates, but also in ongoing
symptom control and treatment. In Australia, it was estimated that in 2013-2014, the
Pharmaceutical Benefits Scheme (PBS) provided payments totalling AUD$1.7 Billion
(17% of total payments) for cardiovascular related medications (Nichols et al., 2016).
Major dietary, lifestyle, and metabolic risk factors for CVD have been identified (e.g.
hypertension, high blood cholesterol, smoking, sedentarism, and obesity), however,
the majority of these manifest in adult life and for some people these signs and
symptoms come too late to allow for any meaningful lifestyle change.
The Developmental Origins of Health and Disease (DOHaD) paradigm suggests that
the early environment, specifically the uterine environment, may have an effect on
cardiovascular morbidity and mortality. DOHaD is a new health and research
paradigm that was born in the 1980s from a growing body of evidence indicating that
poor fetal growth can have life-long consequences for chronic health conditions
(Barker, 1994). Longitudinal studies in humans and experimental studies using
animal models (see section 1.5) have since supported and refined the concept that
insults in early life influence subsequent mortality in adulthood from diseases
including cardiovascular disease (CVD) and stroke (Baird et al., 2016).
Within the DOHaD paradigm, there has been a strong research emphasis on birth
weight as the independent variable representing the quality of the uterine
environment the developing fetus has experienced. This has proven fruitful with a
consistent association between reduced birth weight (or fetal growth) and increased
risk of hypertension and CVD. This consistent inverse relationship has been evident
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in times where infant and maternal mortality were low, as found in The Aberdeen
Children of the 1950s study cohort (Lawlor et al., 2005). This cohort of 10,803
singleton births lived through a time of profound improvements in infant and maternal
health, therefore, factors other than the quality of healthcare, namely, genetics and
variations in placental function were implicated (Lawlor et al., 2005).
Focusing on birth weight as the main measure of the early environment, however,
has misdirected the research focus to some extent. Birth weight is an outcome of the
uterine environment rather than a cause of CVD. Birth weight is at the end of a long
nutrition and oxygen supply line from the mother via the placenta to the fetus.
Because of this relationship, the uterine environment, placenta and fetal growth are
inextricably linked. Therefore, examining an alternative measure of the early
environment – placental weight – and its association with subsequent cardiovascular
health may provide additional insights. This is of particular interest when it is
recognised that a range of proposed cues (e.g. oxygen and nutrient levels, stress,
and hormone levels) present during pregnancy are either influenced or regulated by
the placenta and it is this which ultimately determines the physiological fitness of the
heart (Thornburg et al., 2010). It has been calculated, from a sample of 24,152
singleton liveborn children from the Collaborative Perinatal Project, that placental
weight alone accounted for 36.6% of birth weight variation (Salafia et al., 2008).
In order to quantify the strength of the association between placental weight and
cardiovascular disease risk, the present study will synthesise published research and
conduct a meta-analysis to provide a deeper and more complete understanding of
the association between placental weight and CVD.
The aim of this project is to bring together and evaluate the placental weight and
cardiovascular health literature and attempt to quantify this relationship through the
calculation of an effect size. This knowledge will contribute to our understanding of
12

the significance of the early environment for CVD and potential interventions aimed
at improving placental and fetal growth and development.

1.1

Hypertension and Cardiovascular Disease.

Chronic non-communicable diseases exhibit an increasing health burden on the
world’s population. Cardiovascular disease (CVD) is a major chronic, noncommunicable disease and the World Health Organisation (WHO) reported that
globally in 2015, there were 17.7 million deaths attributed to CVD (equating to 31%
of all global deaths or 45% of deaths by non-communicable diseases) and Australia
is no exception (WHO, 2017). Nichols et al. (2016), reported that CVD was
responsible for 45,392 deaths in Australia in 2015 (nearly 30% of all deaths). The
burden of disease is seen not only in mortality, but also in ongoing treatment as our
health services improve. It was estimated that in 2013-2014, the Pharmaceutical
Benefits Scheme (PBS) in Australia provided AUD$1.7 Billion worth of payments
(17% of total payments) for cardiovascular related medications (Nichols et al., 2016).
The WHO defines CVD as diseases of the heart, vascular diseases of the brain and
diseases of blood vessels, and categorises all CVDs into two groups, CVDs due to
atherosclerosis and CVDs due to other causes. CVDs such as ischaemic heart
disease (IHD) or coronary heart disease (CHD, of which ‘heart attacks’ are listed as
a prime example), cerebrovascular disease (stroke), disease of the aorta and
arteries, including hypertension and peripheral vascular disease, are all in the first
category. The second category includes congenital heart disease, rheumatic heart
disease, cardiomyopathies and cardiac arrhythmias (WHO, 2011).
The WHO lists hypertension as a leading cause of CVDs as it is a key metabolic risk
factor for atherosclerosis. Hypertension as a risk factor is recognised through the
measurement of systolic and diastolic blood pressures (reported in mm Hg as
SBP/DBP e.g. 120/80 is a SBP of 120 mm Hg and a DBP of 80 mm Hg). The risk of
13

CVD may double for each incremental increase of 20/10 mm Hg beginning at 115/75
mm Hg, leading to CHD and cerebrovascular disease. Furthermore, uncontrolled
hypertension contributes to heart failure, renal impairment and peripheral vascular
disease, as well as visual impairment as it may damage retinal blood vessels (WHO,
2011).
According to both the WHO and the National Heart Foundation of Australia (NHFA),
hypertension is intrinsically linked to CVD. The WHO released a “Global Brief on
Hypertension” in 2013 naming it the ‘silent killer’ and a ‘global public health crisis’
(WHO, 2013; Nichols et al., 2016). Hypertension contributes to the burden of CVD,
stroke and kidney failure and in many cases leads to premature mortality (WHO,
2013). Of the 17.7 million deaths due to CVD worldwide in 2017, it was estimated
that hypertension was responsible for at least 45% of coronary heart disease deaths
and 51% of deaths due to stroke (WHO, 2017).
The NHFA and the WHO recognise that the majority of deaths due to CVD are in low
to middle socio-economic regions of the world. In the more developed regions the
outlook for CVD is positive due to improved health and medical services (WHO,
2013; Nichols et al., 2016). The knowledge base regarding CVD risk factors has
developed largely from the Framingham Heart Study, which began in 1948, and was
conducted by the National Heart, Lung, and Blood Institute (NHLBI) of the United
States (Franklin & Wong, 2013). The Framingham Heart Study has led to the
identification of the major CVD risk factors - high blood pressure, high blood
cholesterol, smoking, obesity, diabetes, and physical inactivity. In addition, a great
deal of valuable information has been collected on the effects of related factors such
as blood triglyceride and High Density Lipoprotein (HDL) cholesterol levels, age,
gender, and psychosocial issues (Franklin & Wong, 2013). These risk factors
manifest in adult life and for some these signs and symptoms may come too late to
allow for any meaningful life change.
14

The known modifiable risk factors for CVD are largely based on lifestyle and
nutrition. Danaei et al. (2009) estimated the mortality effects of twelve modifiable
dietary, lifestyle, and metabolic risk factors in the United States of America (USA)
and identified that smoking together with high blood pressure were responsible for
the most deaths in the USA. Sedentary behaviour is another risk factor that is
currently receiving attention, after Wilmot et al. (2012) performed a systematic review
and meta-analysis which identified that more sedentary time was associated with a
significantly increased risk of cardiovascular disease (RR=2.47; 95% CI: 1.44, 4.24)
and cardiovascular mortality (HR=1.90; 95% CI: 1.36, 2.66).
The Developmental Origins of Health and Disease (DOHaD) paradigm suggests that
the early environment, specifically the uterine environment, may have an effect on
cardiovascular morbidity and mortality (Baird et al., 2016). Thus, understanding the
risk factors for CVD in the early years, particularly during gestation and at birth has
the potential to provide long-term benefits in reducing the burden of CVD.

1.2

Developmental Origins of Health and Disease (DOHaD).

DOHaD is a new health and research paradigm that was born in the 1980s from a
growing body of evidence indicating that poor fetal growth can have life-long
consequences for chronic health conditions (Barker, 1994). Longitudinal studies in
humans and experimental studies using animal models (see section 1.5) have since
supported and refined the concept that insults in early life influence subsequent
mortality in adulthood from diseases including cardiovascular disease (CVD) and
stroke (Baird et al., 2016).
The DOHaD paradigm highlights the importance of the early environment for health.
The premise is that certain diseases (including cardiovascular disease, obesity, type
2 diabetes and metabolic disturbances, osteoporosis, chronic obstructive pulmonary
disease, some forms of cancer, and mental illnesses) have their origins in the very
15

early stages of life (conception, pregnancy, infancy and early childhood) (Barker,
2003). Initial studies that generated the original Barker Hypothesis, and the idea of
uterine programming, which later became DOHaD, were conducted by David Barker
in Hertfordshire, England. Thanks to the meticulous records of midwives in the
county under the leadership of Ethel Margaret Burnside, Barker was able to follow up
these babies 50 years later and found an association between their birth records and
adult disease patterns (Barker, Bull, Osmond, and Simmonds, 1990).
There had been concern at the start of the 20th Century that the health of the British
population was in decline and it was decided in 1903 to vigorously preserve the life
of every infant born. In 1911, Ethel Burnside was appointed “chief health visitor and
lady inspector of midwives” in Hertfordshire. She proceeded to organise and train
midwives of the county to educate new mothers on ways to keep their newborns
healthy. Part of her duties was to keep records of infant birth weight plus weight at 1
year (Barker, 2003).
In the 1980s at Southampton University, David Barker and his research group began
the search for maternity and infant health records from the early 20th Century. Many
had been destroyed but some had been preserved and although the quality of the
observations was inconsistent, varying from county to county, the largest and most
complete set of recordings were those of Ethel Burnside and her team in
Hertfordshire (Barker, 2003).
From this point Barker & Osmond (1986) could see that there was an association
between infant mortality, childhood nutrition and ischaemic heart disease. They
found a strong correlation between the rate of infant mortality at the time of birth and
the development of ischaemic heart disease in the surviving babies later on in life.
The records showed that a birth cohort with a high infant mortality rate, most likely
due to poor nutrition, were more likely to develop ischaemic heart disease. They
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investigated the causes of infant mortality only to find that it was largely due to
adverse environmental conditions (poor living standards) (Barker & Osmond, 1986).
Barker and Osmond’s early work was shaped by Chapin’s 1909 ideas that the
nutrient intake of infants has a bearing on their metabolism later in life. It was
surmised that since fat is the major source of energy in human milk and has a
correlation to ischaemic heart disease (IHD), it could be that fat metabolism is the
associating factor between early life nutrition and adult disease (Barker & Osmond,
1986). Although they could not measure the early uterine environment in this
instance, birth weight was used as a proxy for the supply of nutrients to the fetus.
As nutrition was central to Barker and Osmond’s concerns, it is important to consider
both the nutrition of the mother and that of the fetus. Intrauterine growth of the fetus
is both a function of the mother’s health and nutritional status and the fetal supply
line including the efficiency of the placenta that ultimately nourishes the fetus. Barker
et al. (1990, 1993) found that it is placental efficiency (how many grams of baby are
produced per gram of placenta), which leads to a healthy birth weight. In turn, it is
placental insufficiency that leads to intrauterine growth restriction (IUGR) which is
now recognised as one of the markers of the early environment that subsequently
contributes to an increased risk of adult disease.
Barker (2003) stated that being small at birth or during infancy is a key indicator that
sets people on developmental trajectories for the rest of their lives, with altered
physiology that may ultimately increase their disease risk. He listed the following
observed characteristics which set these people apart.
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They have higher blood pressures and are more likely to develop type 2
diabetes. They have different patterns of blood lipids, reduced bone density,
altered stress responses, thicker left ventricular walls, less elastic arteries,
and different hormonal profiles, and they are ageing more rapidly. Out of
these observations has arisen the fetal origins hypothesis, which proposes
that cardiovascular disease originates through the responses of a fetus or
infant to undernutrition that permanently change the structure and function of
the body.
(Barker, 2003, p. 1430)

1.3

Birth Weight, Fetal Growth and Cardiovascular Disease.

Nutrition from birth through to adulthood has been identified as a contributing factor
to high blood pressure and cardiovascular disease, therefore consistent with the
DOHaD paradigm, it is likely that the nutritional status of an individual before birth
will also be a significant factor. For many years, the nutritional status during
gestation was summarised as the birth weight of the individual, which is routinely
measured. Intuitively and empirically, a low birth weight is understood to be a poor
outcome of gestation and depending on the severity it can reduce the individual’s
survival probability.
The WHO defines low birth weight (LBW) as less than 2500 grams and recognises
that LBW is a significant public health matter by setting a 30% reduction target of
LBW by 2025 (WHO, 2014). This target is focused on reducing preterm births in
developing countries by improving antenatal care, nutrition and education. This is an
admirable goal, however, not all low birth weight babies are preterm and not all
preterm babies are of low birth weight (Wilcox, 2001). Therefore, reducing preterm
birth may result in even more low birth weight babies being born. We are then faced
with a situation where term babies have experienced their entire gestation under
18

restricted conditions, which may sometimes be diagnosed as intrauterine growth
restriction. Intrauterine growth restriction (IUGR) has been defined as a rate of fetal
growth that is less than normal for the growth potential of the fetus for that
gestational age (Blair et al., 2005; Longo et al., 2013). The crucial mediator between
the maternal environment, fetal growth and intergenerational health is the placenta,
which is not as well studied.
Many investigations into the association between the uterine environment and
subsequent health outcomes have focused exclusively on birth weight. In a study of
12,150 births from The Aberdeen Children of the 1950s study (born 1950-1956),
Lawlor et al. (2005) investigated the association between birth weight of 10,803
singleton births and vascular outcomes. The incidence of coronary heart disease and
stroke were measured by way of hospital admissions or fatalities from these
diseases, and an inverse relationship between birth weight and both these diseases
was found. Furthermore, the authors stated that this was significant in times where
infant and maternal mortality were low, indicating that this association held even
when environmental circumstances were favourable to both the mother and child
(Lawlor et al., 2005). The authors further state that the relationship was very strong
and it is also independent of a number of factors, including adjustment for size in
later childhood, social class and maternal and pregnancy characteristics. In addition,
as the The Aberdeen Children of the 1950s study cohort lived through a time of
profound improvements in infant and maternal health, Lawlor et al. (2005) noted that
factors other than the quality of healthcare were at work, namely, genetics and
variations in placental function. In their findings, Lawlor et al. (2005) surmised that
the discovery of an inverse relationship between birth weight and incidence of
cardiovascular disease at a time when there was low infant mortality strengthened
the argument that birth weight could be an important predictor of cardiovascular
disease.
19

This inverse association between birth weight and CVD mortality is also found when
birth weight and subsequent blood pressure are investigated in observational
studies, further supporting the link between birth weight, hypertension and CVD. A
meta-analysis of 20 articles (reporting 27 original studies) showed that the inverse
relationship was present with babies born of low birth weight (< 2500g) showing an
increased risk of hypertension (OR=1.21; 95% CI: 1.13, 1.30) compared to a birth
weight greater than 2500g. Similarly, mean systolic blood pressure (SBP) was
shown to increase by 2.28 mm Hg (95% CI: 1.24, 3.33) in the low birth weight group.
Conversely, babies of high birth weight (> 4000g) had a 2.08 mm Hg decrease in
mean SBP compared to babies with birth weights less than 4000g (95% CI: -2.98, 1.17) (Mu et al., 2012).
Whether birth weight increased the risk of death generally or was specific to CVD
was also explained. A meta-analysis that investigated 36,834 deaths using birth
weight as the key predictor, has provided some insight into all-cause mortality, CVD
mortality and cancer mortality, by calculating hazard ratios (HRs) and 95%
confidence intervals (95% CI). From the 22 studies analysed, it was calculated that
CVD mortality had a stronger inverse association with birth weight (HR=0.88; 95%
CI: 0.85-0.91) than all-cause mortality (HR=0.94, 95% CI: 0.92-0.97) (Risnes et al.,
2011). Other mortality categories which were not consistently predicted by birth
weight include cancer, cirrhosis of the liver, diabetes, diseases of the nervous
system, lung diseases and mental disorders (Risnes et al., 2011).
Evidence also suggests that the association between birth weight and vascular
health varies between males and females. Gamborg et al. (2007), on behalf of the
NordNet Study Group, performed a meta-regression analysis of 20 Nordic studies
that synthesised the data from 197,954 births and found an inverse relationship
between birth weight and systolic blood pressure (SBP) and a linear association with
males and females having a birth weight greater than 4 kg. They estimated the effect
20

of birth weight on SBP at age 50 years for men to be -1.53 mm Hg/kg (95% CI: 2.27, -0.77) and for women -2.80 mm Hg/kg (95% CI: -3.85, -1.76). The effect on
women was nearly twice that of men. Due to these sex differences, this present
study has attempted, where possible, to explore the evidence of an association
between placental ratio and CVD for women and men separately.
This strong research emphasis on birth weight has consistently shown an
association between blood pressure and CVD, however, this has misdirected the
focus to some extent. Birth weight is an outcome of the uterine environment rather
than a cause of CVD. To further our understanding of the uterine environment, the
relationship between the placenta and birth weight needs to be considered at the
gross level as can be seen in a sample of 24,152 singleton liveborn children of the
Collaborative Perinatal Project, where it was found that placental weight alone
accounted for 36.6% of birth weight variation; the six other placental measures
accounted for 28.1%. Combined, all placental measures accounted for 39.1% of birth
weight variation (Salafia et al., 2008). The current study will establish the pooled
effect size of placental weight and contribute to the future understanding of the
predictive power of the early environment, specifically the placental weight and the
subsequent development of CVD and hypertension.

1.4

Placental Weight, Placental Efficiency and Cardiovascular
Disease.

As the growth of the fetus is determined to a large extent by the uterine environment,
it can be seen that fetal growth, LBW and IUGR and the placenta, are inextricably
linked. Fetal growth is dependent on the uterine conditions as nutrients are
transported from the mother to the fetus via the placenta (Godfrey & Barker, 2000).
Indeed, the importance of birth weight as a proxy for the end product of a long
oxygen and nutrition supply line, has been questioned. For example, studies such as

21

those using data from the Dutch Hunger Winter Famine, suggest that early life
exposures (predominantly maternal undernutrition) may not affect size at birth, yet
still influence chronic disease risk (Barker, 1993; Ravelli et al., 1998; Lunney, 1998;
Roseboom, 2011). As such, it may be that we need to look beyond birth weight and
focus on attempting to identify additional factors that influence fetal growth (Whincup
& Owen, 2006; Salavati et al., 2019).
The most common pathophysiological mechanism for fetal growth restriction (FGR)
is placental insufficiency. FGR fetuses are seen to occur in all fetal weight categories
(small, appropriate and large for gestational age), however, there are limited studies
focusing on placental morphometry and FGR. A recent review conducted by Salavati
et al. (2019) indicated that morphometric data such as placental dimensions/shape
and weight should be further explored as they contribute to placental insufficiency
and can help to identify FGR. Moreover, placental conditions are the most frequent
aetiology of IUGR (Mandruzzato et al., 2008). Key placental characteristics such as
chorioangioma, infarction, circumvallate placenta, confined placental mosaicism and
obliterative vasculopathy of the placental bed are all possible causes of IUGR.
Therefore, examination of placental characteristics is a worthwhile activity to
understand FGR and IUGR and provides an additional predictive factor for the risk of
both reduced fetal growth and premature cardiovascular disease. If reliable
predictors can be found, the potential to reduce the consequences of poor in-utero
growth exist (Mandruzzato et al., 2008).
A gross estimate of placental efficiency is calculated from its weight and the
relationship between placental weight and birth weight has been demonstrated on
several occasions in various cohorts around the world (Barker et al., 1990; Whincup
et al., 1995; Godfrey & Barker, 2000). In a review of the placental origins of chronic
diseases, Burton et al. (2016) defines one measure of placental efficiency to be the
amount of fetal body mass accumulated per gram of placenta, as the key indicator of
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the offspring’s resilience and susceptibility to chronic disease in later life. Burton et
al. (2016) note that based on this measure of placental efficiency, the human
placenta is relatively inefficient, suggesting that other evolutionary selective
pressures have been more significant, namely, the placenta’s ability to mitigate
maternal and environmental stressors through its endocrine and epigenetic
adaptability.
In recent times, larger longitudinal studies have added to the evidence base
supporting the predictions of DOHaD and highlighted the importance of the
placenta’s role in the uterine environment. Analysis of the Trondheim Cohort from
Norway, a study of 31,307 Norwegians born between 1934 and 1959, found that the
placental weight to birth weight ratio (placental ratio) was positively associated with
cardiovascular disease mortality (Risnes et al., 2011). They concluded that either a
disproportionately large placenta or a relatively growth restricted fetus increases the
amount of work a fetus’ cardiovascular system needs to do and that this has
consequences for development, specifically of the fetal cardiomyocytes. This, in turn,
may limit capillary formation in the myocardium and lead to a poorly developed and
susceptible cardiovascular system (Risnes et al., 2011).
The consistent nature of these findings is further supported by the presence of
similar associations in populations from developing countries. This is exemplified by
the Mysore Parthenon study in Southern India with which Winder et al. (2011)
investigated the factors that influence placental morphology. The authors concluded
that the mother’s nutritional status and body size (mother’s height was measured in
this study) were associated with greater placental efficiency. The neonates in this
cohort are too young to follow up for cardiovascular mortality at present; however, an
analysis of the 9.5 year blood pressure data concluded that the children’s blood
pressure at 9.5 years can be predicted by the size and shape of the placental
surface (Winder et al., 2011). This demonstrates the value of understanding factors
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that influence the development of an efficient placenta and confirms that they apply
in different environments and cross-culturally. Examination of the published evidence
and estimating effect sizes in the current study should not only develop our
understanding of associations between fetal growth, placental weight and
cardiovascular disease, but may also contribute to the knowledge of which
populations are more susceptible and require increased monitoring.
In addition, other anthropomorphic markers of the uterine environment have also
been used. Measures such as ponderal index, head to chest circumference ratio and
placental ratio may be more sensitive indicators of restricted growth rather than birth
weight and their association with CVD needs to be investigated. Using data from the
Collaborative Perinatal Project in the United States, Hemachandra et al. (2006)
examined 29,710 births between 1959 and 1965. At birth, anthropomorphic
measurements such as birth weight, placental weight, and head and chest
circumference, were obtained, and from this data they calculated the placental ratio,
ponderal index and head to chest circumference ratios. The placental ratio is a
common proxy for placental efficiency and is defined as the amount of fetus (in
grams) produced per gram of placenta. The subjects were followed up and in their
seventh year, their blood pressures were taken. Of all the measurements available, it
was the placental ratio percentage, that is the weight of the placenta expressed as a
percentage of the birth weight (calculated by dividing the placental weight by birth
weight then multiplying by 100), that was associated with an increased risk for high
systolic blood pressure and pulse pressure at seven years of age (Hemachandra et
al., 2006).
Although hypertension is rare among children, Misra and colleagues (2010) noted
that blood pressure does track from childhood into adulthood. Several longitudinal
studies have found that if a child has blood pressure at the higher end of the
distribution, they are more likely to have hypertension as adults. They further
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commented that there is a considerable amount of effort in place, focusing on
nutrition and physical activity, which targets children at risk of developing
hypertension in adult life. If we follow the DOHaD paradigm, there is considerable
evidence supporting the idea that factors prior to the birth of the child are also at
work. A subset of the Collaborative Perinatal Project (15,902 births) was analysed
and it was found that birth weights smaller or larger than the predicted placental
weight have a predictive effect on future blood pressure and body mass index (BMI).
This effect was found to be independent of other measurements (Misra et al., 2010).
The placenta gives unique insight into intrauterine conditions and placental growth
may be linked to an increased life-time risk of hypertension and cardiovascular
disease. Through calculating effect sizes, this present study aims to quantify the
influence of the early environment more accurately in order to provide the evidence
base for or against early interventions.

1.5

Birth weight, placental weight and cardiovascular disease:
Summary.

In summary, the association between the uterine environment and its subsequent
health consequences in humans has produced mixed findings, particularly with
regard to the role of the placenta. This relationship was further investigated in
relation to blood pressure and Barker (1997) discovered that at any given birth
weight, blood pressure rose as placental weight increased. He suggested that
people with the highest blood pressures as adults were in-utero, sacrificing their own
growth to support placental growth, resulting in an increased placental ratio: a larger
placenta with a smaller baby (Barker, 1997). This highlights how valuable placental
growth is and that the placenta plays a key role in the uterine environment.
Development of the fetus and birth weight are outcomes of this uterine environment
and understanding the effect of the placenta on them and cardiovascular morbidity
and mortality is crucial.
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Although some studies find evidence for an important role of the placenta beyond
that of birth weight (e.g. Hemachandra et al., 2006; Misra et al., 2010), others find
birth weight is the key predictive factor (e.g. Blake et al., 2001; Huang et al., 2007;
Lawlor et al., 2005). For example, Blake et al. (2001) studied 2,507 births between
1989 and 1992 and recorded blood pressure at age 1, 3 and 6 years. In contrast to
Barker (1997), they concluded that there was an inverse relationship between
placental weight and blood pressure at 1, 3 and 6 years. However, there was no
consistent relationship between placental weight and later blood pressure within birth
weight categories and based on this finding, they surmised that it was not clinically
significant.
What we do know is that it is generally accepted that birth weight has been a long
standing predictor of infant mortality and FGR (Wilcox, 2001; Salavati et al., 2019). It
is reasonable to link fetal nutrition with fetal growth and ultimately birth weight. The
ease of measurement and attainment of birth weight records has fostered a huge
body of data examining birth weight and numerous infant and adult health outcomes
(Wilcox, 2001). Birth weight itself, however, does not wholly explain the
developmental consequences of placental insufficiency, IUGR or FGR, which does
indicate that birth weight should be related as an outcome of placental insufficiency
rather than a cause of future disease (Wilcox, 2001). It has been noted recently that
in a normally nourished population, the small for gestational age (SGA) group may
include those exhibiting placental insufficiency, those in which no signs of placental
insufficiency have been detected or represent unknown or undetected causes of
placental insufficiency or those with congenital malformations or infections (Figueras
& Gratacos, 2017). In order to separate out the cause, that is, maternal and fetal
nutrition from the effect, which is measured as placental and fetal growth, animal
models have been utilised.
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1.6

Animal Models

Animal models have been usefully applied in biology and medicine to investigate
potential mechanisms underlying associations seen at the group level. These models
are particularly useful for investigating the mechanisms behind DOHaD effects,
consequently, a number of small and large animal models as well as novel models
have been developed for this purpose (Bertram & Hanson, 2001). Animal models
have long been used to demonstrate that maternal nutrition may program adult
disease (Bertram & Hanson, 2001). Indeed the first experiments relating to the
current DOHaD concept may have been run over 50 years ago by Winick & Noble
(1966). The association between birth weight and CVD noted by Barker and
colleagues (1990, 1993, 1994, 1997) worldwide have been supported through the
use of animal models. Therefore, the following section will discuss the use of animal
models to investigate mechanisms underlying the DOHaD phenomenon. These
models have been used to develop the knowledge base of DOHaD and continue to
refine our understanding of the effect the placenta has in animal populations.
These models indicate that insults during critical periods of embryonic and fetal
development can have permanent long-term effects on organ structure and function,
and regulatory systems of the body, which ultimately impact adult health (Jones et
al., 2012). Collectively, it has been shown that effects on the placenta or fetal heart
depend on the nature of the challenge and the duration, severity and timing in
relation to the development of the heart and placenta (Camm et al., 2018).
Presently, there are a number of established animal models used with some being
less invasive, for example, using dietary protein restriction or global nutrient
restriction to induce IUGR (McMullen & Mostyn, 2009; Jones et al., 2012). Others
are more invasive, using techniques such as uterine ligation or the in-utero removal
of part of the placenta (Bertram & Hanson, 2001; McMullen & Mostyn, 2009). These
animal models demonstrate that IUGR offspring develop post-natal hypertension, a
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known contributing factor to cardiovascular disease. Small animal models, such as
mice, rats and guinea pigs, also have a number of benefits including shorter
gestation times and short lifespans which affords us the opportunity to investigate
the DOHaD concept in ways that cannot be done in humans (Jansson & Lambert,
1999; Bertram & Hanson, 2001; Symonds, et al., 2007; Wyrwoll et al., 2007;
McMullen & Mostyn, 2009; Camm et al., 2018).
A range of animal models have been used to investigate environmental factors that
link the phenotypic characteristics of the placenta to those of the heart. These
models comprise three broad groups: 1) Those that reduce oxygen and nutrient
delivery to the fetus (these include various forms of ligation of the key arteries and
veins); 2) Those that reduce oxygen availability for transfer to the fetus (these
include various forms of inhalation hypoxia); and 3) Those that alter nutrient
availability for the fetus (these include maternal dietary restrictions) (Camm et al.,
2018). The methods employed in these three categories cannot be ethically
replicated in randomised trials of human populations, therefore, for human
populations, it is left to observational studies or studies based on natural
experiments (e.g. the Dutch Famine and other factors which may impose a dietary
restriction) or in cases of clinical placental pathology such as abnormal umbilical
cord insertion (Camm et al., 2018). A fourth group does exist as the administration of
glucocorticoids (usually synthetic) in experimental animal models and in humans to
hasten development in pre-term birth. Due to the weight of evidence from animal
experiments it is generally accepted that the efficiency of the placenta is associated
with the efficiency of the cardiovascular system.
Furthermore, animal models have the added dimension of experiments conducted
on genetically modified organisms. In describing the relationship between placental
formation and fetal heart development, findings from genetically modified mouse
experiments suggest that fetal heart development requires several genes which also
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regulate the development of the placenta (Camm et al., 2018). This adds further
evidence to the causal nature of the association between placental function and
heart development.
A search of The Mouse Genome Informatics database, conducted in February 2018
by Camm et al., identified 329 genes with both placental morphology and
cardiovascular defects (2018). 24 of these genes were included in a review of
placenta and fetal heart interactions and all of these genes highlight the impact of
placental development on fetal heart formation and growth, with malformations of the
heart and placenta cited as the most common cause for mid-gestational lethality in
mice (Camm et al., 2018). Furthermore, the previous focus was largely centred on
assessing the impact of a genetic manipulation rather than the interaction between
placental formation and cardiac development (Camm et al., 2018).
The physiological relevance of some animal models is questioned, often cited
differences include the dietary requirements and the physiology and reproductive
capacity, particularly of small animal models, as negatives (Bertram & Hanson,
2001). It is true that rats or mice have different diets to humans, different disease
profiles and their offspring are born with immature nervous systems in litters rather
than singleton births with relatively mature nervous systems (a functioning
Hypothalamic–Pituitary–Adrenal axis or HPA axis) common in humans. The guinea
pig model has been used as the invasiveness of the placenta is significant and their
offspring are relatively mature at birth, however, the other drawbacks of dietary and
disease profile still remain (Bertram & Hanson, 2001; McMullen & Mostyn, 2009).
Even in the face of these drawbacks, rat and mouse models using uterine artery and
vein ligated placenta have been shown to result in hypertensive offspring in rats and
mice (Bertram & Hanson, 2001).
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Large animal models which are less like the rat and mouse model, are used by
researchers as some are perceived to be closer to humans in physiology. Three
large animal models considered are the sheep, the pig and non-human primates, all
of which have offspring born with a functioning HPA axis. Non-human primates
afford us the greatest insight, however, ethically, morally and financially the use of
such a model is controversial and restricted. There are other factors that impact on
the use of non-human primates such as the age at reproductive maturity, which
could be between 4 and 7 years. This incurs a further increase in costs for care in
captivity, as well as our responsibility for their physical and mental well-being
requiring many resources and expertise. In most countries, these factors are
prohibitively expensive (McMullen & Mostyn, 2009).
Natural experiments in pig and sheep populations occurring on farms, have provided
supporting anecdotal evidence for the relationship between the placenta and fetal
development, and these results are anecdotally referred to as the ‘runt of the litter’
effect (Bertram & Hanson, 2001). In a commercial age where every animal born
needs to provide a monetary return to the farmer, it is considered an important factor
to study in order to avoid financial loss. Natural experiments in pigs occur due to the
anatomy of the pig’s uterus, as it is ‘U’ shaped, the fetus attached to the ends of the
arms of the ‘U’ have a natural restriction and it is easily a demonstration of how a
naturally restricted placenta results in poor birth outcomes such as LBW.
Experiments in sheep in which ligation of placentae are easily done due to the bilobed nature of the sheep’s placenta reduced the overall size of the ligated placenta
by half, and the resulting offspring exhibit IUGR characteristics (McMullen & Mostyn,
2009).
Where the sheep fails to match humans in dietary intake, the pig matches a human’s
omnivorous diet and so, a porcine model for DOHaD is emerging. In the porcine
model, due to the large litter size and variability in uterine environment, piglets of the
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same litter may have up to a 3-fold difference in birth weight. It is this unique feature
of the pig and the fact that they can be assessed within litters which provides a
natural model of variable fetal growth conditions (McMullen & Mostyn, 2009).
With regard to the investigation of DOHaD and cardiovascular disease, animal
models routinely demonstrate that IUGR results in hypertensive offspring. Alexander
(2003) conducted an experiment on rats whereby placental perfusion was reduced to
induce IUGR and observed that the IUGR rats had a marked elevation in mean
arterial pressure at four, eight and twelve weeks of age when compared to controls.
Furthermore, at twelve weeks of age, the rats showed a differentiation based on sex,
with IUGR male rats showing an increased mean arterial pressure vs male controls
(158±1 versus 135±2 mm Hg, P<0.01), whereas female IUGR rats showed an
increase that was not significant (139±4 versus 126±3 mm Hg; IUGR versus control,
respectively, no p-value supplied) (Alexander, 2003). Ojeda et al. (2008) states that
animal models have been used to demonstrate how an environment of under
nutrition, by reducing uteroplacental perfusion during late gestation, leads to
hypertension in the IUGR offspring. Findings such as these in animal models parallel
human epidemiological studies where reduced placental efficiency is related to
cardiovascular mortality and morbidity in the offspring.
Animal models have also afforded proof of concept for DOHaD by allowing
investigations into specific causal mechanisms. They provide an analogy enabling us
to study the DOHaD concept and allow us to experiment in ways that would be
unethical, immoral or unfeasible in a human population. Bilateral uterine blood vessel
ligation in rat models has been used to induce uteroplacental insufficiency and this
has been associated with reduced birth weights and increased systolic blood
pressure and pulse pressure in adult rats (Schreuder et al., 2006). One of the most
likely mechanisms appears to be a reduced number of nephrons in the kidneys of
these growth restricted animals. This appears to hold for several animal models
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including diet restriction (Woods et al., 2004). This association between lower birth
weight, a reduced nephron number and increased blood pressure is also supported
by human data (Hughson et al., 2003; Manalich et al., 2000). Animal models
continue to be refined with new guidelines specific to their use in DOHaD research in
order to continue accumulating knowledge into the effects of genome, environment
and epigenetics (Dickinson, 2016).

1.7

Epigenetics and DOHaD.

The role epigenetics play in the DOHaD paradigm has also been investigated using
animal models. This is of particular interest as the paradigm views the fetal insult as
a ‘programming’ process implying the embodiment of the stressor as a precondition
for disease in later life. A mouse model showed that there are at least two global
epigenetic reprogramming events which can be related to the DOHaD concept, the
first being the mass deletion of the parental genome followed by a selective
epigenetic re-programming of the gametes during gametogenesis while the second
occurs after fertilisation within the zygote which enables the pluripotency of the cells
(Symonds et al., 2007).
The mouse model provides support that in humans, following fertilisation, maternal
and paternal genomes (excluding the imprinted genes) of the developing zygote
undergo demethylation in order to ensure that the cells are pluripotent. This
demethylation is undone in 70% of Cytosine-phosphate Guanine dinucleotides
(CpGs) prior to implantation, but following implantation, DNA methylation continues
to be vital in cell differentiation as it silences the expression of specific genes during
the development of tissues and organs. This results in a window of opportunity,
where if an insult were to occur during this time, then variations in gene expression
can result (Godfrey et al., 2007; Einstein et al., 2010).
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In addition to the effect on the offspring’s genome, epigenetic regulation is a
significant factor in the development of the placenta and its function. Nelissen et al.
(2010) reviewed the literature on epigenetics in relation to placental development
and function in order to further examine this claim. It was noted that the proper
epigenetic regulation of both imprinted and non-imprinted genes is crucial to
placental development and this, in turn, is key to a developing fetus (Nelissen et al.,
2010). Showing further support for the DOHaD paradigm, Nelissen et al. (2010),
concluded that various environmental factors can disturb the epigenetic regulation
process leading to abnormal placental development with possible consequences to
the offspring’s susceptibility in later life.
Banister and colleagues (2011) examined 206 human placentae for genome wide
DNA methylation patterns and found that it is possible to use patterns of DNA
methylation to classify IUGR and small for gestational age (SGA) placentae from
appropriate for gestational age (AGA) placentae. A significant difference (p = 0.0007)
in the prevalence of IUGR or SGA placentae was found, which led them to conclude
that DNA methylation profiles and IUGR or SGA placentae are significantly
associated (Banister et al., 2011). This adds a further factor to the complexity of the
placental influence on the growth and development of the fetus. Through epigenetic
modifications of the placenta and its function a complex array of alterations to the
DNA have specific roles in the phenotype. Coall et al. (2015) proposed that
methylation can occur in response to the external environment and this may be
reversible, hence the changes are prime candidates for developmental adaptations
as seen in DOHaD.
It has been observed that the key regulators of growth and development of blood
vessels within the placental villi are members of the Vascular Endothelial Growth
Factor (VEGF) family (David, 2017). These include VEGF-A, or the processed forms
of VEGF-C and VEGF-D which bind to VEGF receptor 2 (VEGFR-2) which result in
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vasculogenesis and angiogenesis in the placenta, increasing placental efficiency. In
IUGR mice models, this is inhibited and a soluble form of VEGF-2 is formed which
binds VEGF-A, subsequently inhibiting its actions (David, 2017).
The preceding reviews of human studies and animal models strongly advocate for
the existence of a link between the placenta and the offspring’s subsequent
cardiovascular health. Thus it can be seen that the DOHaD paradigm is well
supported, however, the mechanism adopted to describe the uterine environment is
not clearly defined. There is a large body of evidence in support of the use of birth
weight while other data shows support for the placental ratio percentage as a marker
of the uterine environment. A range of proposed haemodynamic, growth factor,
stress and nutrient or oxygen cues before birth are either influenced or regulated by
the placenta and it is this that determines the ultimate physiological fitness of the
heart (Thornburg et al., 2010). The next step is to quantify the strength of the
association between placental weight and cardiovascular disease risk. The current
study is a synthesis of the published data and a meta-analysis to provide a deeper
and more complete understanding of the association between placental weight and
CVD. Therefore, generating an effect size from a meta-analysis of observational data
in human populations may contribute further to our understanding of and the value of
potential interventions aimed at improving placental growth, development, and
structure and ultimately function.
This project will:
1) Examine the published evidence on the associations between in-utero growth
of humans (focusing on placental weight measurements and the placental
ratio percentage) on cardiovascular outcomes (hypertension and
cardiovascular morbidity as defined by the WHO ICDs) in adult life by
performing a systematic review.
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2) Use meta-analytical techniques to synthesize the information found through
the systematic review.
3) Use the PRISMA statement to report the findings from the published data on
human studies.

2. Materials and Methods.
2.1

Systematic Literature Search

To examine the published data describing the effect of placental weight on
cardiovascular outcomes, a broad and as complete as possible range of published
work was assessed. To access this work, the search terms were carefully selected
taking into account different spelling, word combinations, research and disease
terms. Search terms included the following and/or combinations of, ‘birth weight’,
‘birthweight’, ‘IUGR’, ‘fetal weight’, ‘foetal weight’, ‘placental weight’, ‘placental weight
ratio’, ‘placental ratio’, ‘hypertension’, ‘high blood pressure’, ‘stroke’ and
‘cardiovascular disease’. The search was restricted to studies on human, singleton
births and articles written in English published up to and including the 30 December
2017. These search terms have been chosen using key definitions set out by the
WHO and are in line with the original findings underlying the Developmental Origins
of Health and Disease paradigm.
A systematic search of the following databases, PubMed, EMBASE and ISI Web of
Science, was conducted and the results recorded in the PRISMA flow chart (Figure
1; Chapter 3 below) and a spreadsheet (Appendix A). Searching the PubMed
database was considered valuable as it covers publications in the biomedical and life
sciences fields of research and is linked to the US National Library of Medicine. This
enabled the search to cover the MEDLINE database (in total PubMed covers 27
million references) and in addition, the database is indexed using a controlled
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vocabulary termed MeSH - Medical Subject Headings. MeSH suggested search
terms which are approximates to the original terms entered for example, ‘placenta
weight’ was recommended by MeSH in lieu of ‘placental weight’. Searching the Web
of Science database, expanded the literature search to include books and
conference proceedings. In addition to journals, this maximised the probability of
accessing grey literature, that is, data which may have been discussed as part of a
conference or book chapter but was not published in a journal. To broaden the scope
of the search further, the EMBASE database was searched as it covers journals that
are not included in the MEDLINE database (searched through PubMed).
The database searching was conducted as follows. First, the BMJ, PLoS One and
PLoS Medicine journals were searched in full, as these are journals of quality where
significant research groups in the field of DOHaD have published repeatedly.
Second, the databases (PubMed, EMBASE and ISI Web of Science) were searched
followed by a Google Scholar search. The Google Scholar search was employed as
an additional layer to maximise reach and diversity as it employs meta-searches
rather than direct database searches. A detailed list of the articles found was
maintained in order to avoid duplicates.
When the systematic literature search was carried out, the relationship between the
placenta and the cardiovascular system was investigated, the most common
placental measures being used were placental weight and placental weight to birth
weight ratio (sometimes referred to as the placental ratio). It is becoming more
apparent that other placental measures such as volume, surface area, length and
breadth are increasingly being used. As more studies using these measurements are
published a better understanding of the placenta’s role in CVD will emerge. As this is
emerging literature, the search criteria for this thesis was focused on placental
weight measurements. In the original defining work by Barker and colleagues (1986),
placental weights were measured in imperial pounds, whereas subsequent
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investigations used metric measurements (grams). The cardiovascular outcomes
have been defined by the WHO using the International Classification of Diseases
(ICD) codes to identify cardiovascular diseases such as ischaemic heart disease
(IHD), coronary heart disease (CHD) and stroke. In addition, blood pressure was
investigated alongside hypertension as blood pressure was sometimes measured in
children and this was seen as separate to diagnosed hypertension in adults.

2.2

Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA).

The best practice guidelines for conducting and reporting meta-analyses and
systematic reviews are provided in the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement, developed and published by The
PRISMA Group. This statement was released via simultaneous publications in the
British Medical Journal (BMJ), Annals of Internal Medicine, PLoS Medicine, Journal
of Clinical Epidemiology, Open Medicine and the International Journal of Surgery.
This statement recognised that while meta-analyses and systematic reviews are
essential tools used to provide a reliable and accurate view of published data, there
is evidence that the published works resulting from a systematic review and/or metaanalysis are often less useful than expected because the key information is not
reported well (The PRISMA Group, 2009). This was most likely due to the lack of a
standard protocol for reporting systematic reviews and meta-analyses. The PRISMA
statement introduced a means for standardised reporting in order to provide a guide
on how to report the findings (The PRISMA Group, 2009). In the current project, the
PRISMA statement guidelines were followed, and in doing so, the transparent and
complete reporting of key information was ensured (The PRISMA Group, 2009), see
Figure 1 for this study’s PRISMA 2009 Flowchart.
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2.3

Statistical Analysis.

Through a systematic review of the published works, a list of studies was created as
displayed in appendix A. The studies were examined and data was extracted from
them in these eleven fields: 1) Publication details (e.g. authors, date and title of
publication), 2) Setting or cohort studied, 3) Recruitment location, 4) Method of
measurement, 5) Diagnostic criteria to determine CVD, 6) Age at outcome, 7)
Number of subjects, 8) Placental weight categories, 9) Other placenta data, 10) Key
findings and 11) Comments.
The studies were grouped according to the type of cardiovascular outcome measure
(e.g. hypertension, coronary heart disease and cerebrovascular disease), and further
stratification was made based on geographical regions and/or population. If data was
available on sex this was also used to group data. Once the groupings were set up,
meta-analytical techniques (as defined by the PRISMA statement) were performed.
To analyse the data a specialised meta-analysis package, Comprehensive MetaAnalysis (CMA) software from https://www.meta-analysis.com/ was used. CMA was
chosen as it does not restrict the type of data entered for the calculation of effect size
and variance to one format, for example, means and standard deviations. The CMA
software accepts more than one hundred formats including the more frequently
used, mean and standard deviation, odds ratio and confidence intervals, increasing
the number of studies that can be incorporated into the analysis.
The first technique was the examination of publication bias which was done through
the use of funnel plots. Publication bias was first formalised by Dickersin & Min
(1993) as a tendency for articles not to be published based on the direction and
strength of the results of a study. It is now one of several biases related to metaanalyses, collectively termed reporting biases (Sedgwick, 2013). A funnel plot is a
plot of the estimated effect size of each trial against its sample size. By including a
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funnel plot we visualised how the individual studies found, through the systematic
review, were related to each other and explored the implications for data
heterogeneity, publication bias and chance (Liu, 2011; Sedgwick, 2013). Of specific
concern was the shape of the plot, as in the absence of bias, the plot resembles an
inverted funnel indicating a balance between positive and negative results exists in
the published literature. The shape comes from the commonly held statistical
understanding that results from studies of smaller sample size will scatter widely
across the bottom of the funnel plot because a smaller sample size lends itself to
greater variability and this spread of effect sizes will narrow as the sample sizes
increase (Egger et al., 1997).
Symmetry can be assessed visually providing a quick method to determine if
publication bias exists, however, to be certain, calculated statistics are employed. In
this instance an Egger’s test was performed. The null hypothesis for Egger’s test is
that symmetry exists in the funnel plot, with the alternative indicating that asymmetry
is present and there is evidence of publication bias (Egger et al., 1997; Sedgwick,
2013). When the Egger’s test was applied, if the resulting p-value was greater than
0.05 it indicated that there was no evidence to reject the null hypothesis in favour of
the alternative, indicating that symmetry was present and there is no evidence of
publication bias. This indicated that at the 5% level of significance it could be
concluded that symmetry exists in the funnel plot. Calculated p-values for the
Egger’s test are recorded in Table 1.
The meta-analysis consisted of three main parts. First, a pooled estimate and
confidence interval for the condition’s effect size was calculated after combining all
the studies. Second, a test for whether the condition’s effect size was statistically
significant or not (i.e. does the effect differ from no effect more than would be
expected by chance?). Third, a test for heterogeneity of the effect on outcome
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between the included studies (i.e. does the effect vary across the studies more than
would be expected by chance?).
Discussion on the value of effect sizes by Sullivan and Feinn (2012) indicated that pvalues are not enough on their own. P-values are greatly influenced by sample size,
with large sample sizes (which are common in this field of research) increasing the
likelihood of a small effect size being statistically ‘significant’ without any clinical
meaning. Therefore, an examination of each study in light of the calculated p-value
and effect size was carried out, with the calculated effect sizes reported whenever
possible. Cumming (2013) stated that effect sizes and confidence intervals provide
the basis for estimation and the use of estimation is superior to null hypothesis
testing. Meta-analytical techniques used in the current project are the key tool in
synthesizing the records found through the systematic literature search. Effect sizes
will quantify the placental risk factor enabling comparisons to other early (e.g. birth
weight) and adult (e.g. hypertension) risk factors for CVD.
Using the CMA software, the relevant data from the records were extracted and
entered in the required fields and then the I2 statistic was calculated. The I2 statistic is
a useful summary of the impact of heterogeneity in a data set as it describes the
proportion of total variation that is due to heterogeneity (Higgins & Thompson, 2002).
An I2 of less than 25% indicates that the studies should be combined using a fixedeffects model as they are homogenous. Alternatively scores of greater than 75% for
an I2 indicate that the studies are highly heterogeneous and a mixed-effects model
should be used (Fernandez & Tran, 2009). After determining that a mixed-effects
model should be used in this study (an I2 more than 25% was reported in section
3.2), a meta-analysis was run and results displayed in Tables 2 and 3. The results
included lower and upper limits for 95% CI, standard difference in means and
variance of each study. These statistics provide a broader picture of the data and an
estimate of the effect of each study on the overall calculated effect size.
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2.4

Examination of Geographical Locations Studied.

Records that satisfied the selection criteria were coded on a heat map of the world in
order to generate a view of the most common locations where these studies were
carried out. A further examination of these records in light of the geographic region
was conducted and this is discussed in section 4.6.

2.5

Grey Literature.

Several records which were found through the search process did not satisfy the
selection criteria and were deemed inappropriate for further analysis. These records
were thoroughly searched and were found to cite two potentially unexplored links to
the topic.
The two possible links were:
1. Eight groups identified by McNamara et al. (2012) who studied early life
influences on cardio-metabolic health in aboriginal populations.
2. A research group working out of the King Saud University who investigated
changes in the placenta during and around Ramadan (Alwasel et al., 2011;
Harrath et al., 2014).
They were searched independently using Google Scholar and PUBMED. In addition,
the corresponding authors were contacted via email as they may also have collected
data which has not been published.

2.6

Selection Criteria.

On completion of the literature search the resulting studies were systematically
reviewed. Search results which did not fulfil the above criteria (in addition to reporting
on placental weights and CVD) were excluded from further analysis, but retained to
provide possible insight and a search of their reference lists was conducted to
extract relevant studies.
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Records were screened using the following criteria:
1) Records were written in English or a duplicate published translation.
2) Records were an original report on the relationship between human placental
weight and blood pressure, hypertension, cardiovascular disease, ischaemic
heart disease, stroke or coronary heart disease. Studies were considered
irrespective of the definition of cardiovascular disease (definitions used
included those of the World Health Organisation and the National Heart
Foundation).
3) Records studied subjects of singleton births, born at full term.
4) Records reported placental weight and the incidence of cardiovascular
disease as described in point 2.
5) Records indicated the geographical and/or ethnic group of the cohort studied
If a record did not fulfil criteria 1, 2, 3 and 4, it was excluded from further analysis as
the record was not usable. The records were retained in order to provide further
insight and for a search of the reference list. Records that did not satisfy criteria 5
were retained and included in the meta-analysis as this criterion did not impact on
the record’s suitability for this meta-analysis.

2.7

Analysis of Study Quality Using the Newcastle-Ottawa Scale.

After the search was conducted and analysis was performed, it became apparent
that further examination of the search results was required to provide additional
evidence by which the quality of each study could be evaluated. The NewcastleOttawa Scale (NOS) was used to assess the quality of the articles reported in this
study and to examine outliers in the data. The NOS was developed in conjunction
with the University of Newcastle (Australia), The University of Ottawa (Canada) and
The Ottawa Hospital Research Institute. It has been used extensively at the
University of Ottawa and the Ottawa Hospital Research Institute, most notably in a
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project assessing the association of CHD with hormone replacement therapy in
postmenopausal women (Wells et al., 2000). The Cochrane Collaboration and the
Agency for Health Research and Quality (AHRQ) have identified the value of the
NOS (AHRQ, 2010; Singh et al., 2015). It is noted that users who are unfamiliar with
the field of research tend to require more training than those who are familiar with
the field (Singh et al., 2015). Therefore, in order to maintain consistency, a
systematic review and meta-analysis that employed the NOS was used as a guide to
the ranking process. The article by Zhang et al. (2013) on, “The Associations of High
Birth Weight with Blood Pressure and Hypertension in Later Life” ranked 30 articles
that had a range of scores from four to nine stars. The author of this thesis read and
ranked the articles according to the NOS and the scores were compared in order to
develop consistent scoring. The present study used the NOS criteria specifically
designed for cohort studies and this is reported in appendix B.
Using the NOS, studies are ranked on three domains: Selection, Comparability and
Outcome, with a maximum of nine stars to be awarded (these ratings are displayed
in Figure 4). Domains for the NOS scale were defined on the basis of the search
criteria of the present study. For example, in the first NOS Domain for ‘Selection’
under the heading, ‘Representativeness of the Cohort’ both the exposed and nonexposed cohort was set to be of all singleton, full term babies in the community
studied. Therefore, a star was awarded if there was ‘full representation’ (all singleton,
full term babies in that population, sample, or hospital) or ‘somewhat representative’
and no stars were awarded if the study was restricted to one sex, for example. Under
the NOS domain for ‘Comparability’, it was noted that as every article found reported
a study which controlled for some factors, such as birth weight or age, it was
deemed that although this was not consistently the same factor, there was an
awareness that some factors in each study were acting as confounders and so one
star was awarded to each study in this domain. According to the NOS guidelines,
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another star was awarded if the study specifically controlled for age, sex and marital
status. The final NOS domain was for ‘Outcome’, and it required an indication of the
median duration of follow-up and it was defined that any study which included rates
of mortality from CVD or incidence of hypertension or CVD was awarded a star
indicating that the duration of follow-up was adequate. Studies which examined
blood pressure (without the key diagnosis of hypertension) were not given a star.
In relation to the NOS scoring system, the Agency for Healthcare Research and
Quality (AHRQ) has indicated that there are three standards, Good, Fair and Poor.
Good quality is defined as: Three or four stars in the ‘Selection’ domain, and one or
two stars in the ‘Comparability’ domain and two or three stars in the ‘Outcome’
domain. Fair quality is defined as: Two stars in the ‘Selection’ domain and one or
two stars in the ‘Comparability’ domain and two or three stars in the ‘Outcome’
domain. Poor quality is defined as: None or one star in the ‘Selection’ domain or no
stars in the ‘Comparability’ domain or none or one star in the ‘Outcome’ domain. One
article, Barker (1997) indicated with an asterix (*) in Figure 4 was ranked but it
reported on data previously published and so was not counted as an original article
for the purposes of the meta-analysis. This is further discussed in section 4.7.
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3. Results.
3.1

PRISMA Flow Diagram.

The process and results of the search of the published literature is detailed in Figure
1. This figure outlines the stages of ‘Identification’, ‘Screening’, ‘Eligibility’ and
‘Inclusion’ with the appropriate number of records and details the prescribed steps at
each stage as outlined by the PRISMA statement. The search identified 826
potential articles through the database search and 18 articles from other sources
such as the reference lists of relevant articles. After removing duplicates, 724
records remained. An initial screening process found that the majority of these
records were reporting on similar cohorts or were responses to the editor and/or
authors of published articles and these 592 records were subsequently removed
from the list. In addition, several records were reference texts, established
procedural guidelines (e.g. guidelines for the pathological examination of the
placenta) or recommendations for changes to the guidelines, which were also
removed. Following this initial screening process, 132 records remained. A further
103 records were excluded as they did not completely fulfil the selection criteria (as
outlined in section 2.5). Although excluded, these 103 records were retained, their
full texts obtained and searched in detail in order to extract any information which
may have been overlooked. Three records were of use as they indicated:
1. Eight groups identified by McNamara et al. (2012) who studied early life
influences on cardio-metabolic health in aboriginal populations.
2. A research group working out of the King Saud University who investigated
changes in placenta during and around Ramadan (Alwasel et al., 2011;
Harrath et al., 2014).
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The appropriate correspondence authors were contacted via the email address
supplied and a detailed search of their reference lists was conducted for potentially
useful records.
The full texts of the remaining 29 records were assessed and 3 were found to be
unsuitable as they either used placental weights as part of a cluster analysis which
analysed Percentage of Expected Birth Weight (PEBW), measured placental weights
as an outcome of exposure to famine or the record was an analysis of a cohort which
was previously included. The remaining 26 records were included in subsequent
analyses. Of the 26, four records were found to reported sufficient data to enter into
the meta-analysis in this study. The results of this meta-analysis are shown in Tables
2 and 3.
On entering the data into the CMA program it became apparent that the various
combinations of data type (e.g. SBP, DBP, diagnosed hypertension, OR, RR, HR,
SMR), placental weight groupings (grouping placentae into three, four and five
groups) and use of differing methodologies (e.g. meta-regression or adjustments for
different variables) would cause the data reported in the records to be incompatible.
To gain a greater understanding of the quality and potential variability between
studies, further analysis of the records was also employed. This included:
1) To examine difference in geographical origins of the cohorts.
2) To examine the quality of the studies using the Newcastle-Ottawa Quality
Assessment Form for Cohort Studies.
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Identification

PRISMA 2009 Flow Diagram

Additional records identified
through other sources
(n = 18)

Records identified
through database
searching (n = 826)

Included

Eligibility

Screening

Records after duplicates removed
(n = 724)

Records screened
(n = 132)

Full-text articles
assessed for eligibility
(n = 29)

Studies included in
qualitative synthesis
(n = 26)

Studies included in
quantitative synthesis
(meta-analysis)
(n = 4)

Records
excluded, (e.g.
review articles,
articles with no
data opinion
pieces).
(n = 103)
Full-text articles
excluded, with
reasons (e.g.
analysed the
same cohort in a
different way,
used placental
weight either as
an outcome
measure or to
characterise
groups in a
cluster).
(n =3)

Figure 1. PRISMA Flow Diagram displaying the number of records at each stage of
the four stages of the prescribed PRISMA process.
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3.2

Meta-Analysis of Records

Of the 26 records, four supplied data in a compatible format which allowed a metaanalysis to be performed and all four records focused on blood pressure as an
outcome measure. One record collected blood pressure readings at three age points
(1, 3 and 6 yrs) and this data was entered as three individual cohorts.The funnel plot
for these records is displayed in Figure 2.
One record (Whincup et al., 1995) was idenitified (shown as a red dot in Figure 2) as
an outlier and the data was analysed again without this record, with the funnel plot
for the repeat analysis shown in Figure 3.

Figure 2. Funnel plot of standard error by standard difference in means, output from
CMA. A record highlighted (red dot) was identified as an outlier. The diamond on the
horizontal axis indicates the spread of the effect size as calculated by standard
difference in means.
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Figure 3. Funnel plot of standard error by standard difference in means, output from
CMA. This plot has omitted the outlier, Whincup et al. (1995), from Figure 2. The
diamond on the horizontal axis indicates the spread of the effect size as calculated
by standard difference in means.

Through visual examination of the plot an outlier was expected. An Egger’s test was
performed to determine the level of heterogeneity in the studies, which leads to the
selection of a mixed-effects or a fixed-effects model. The results of the Egger’s test
are displayed in Table 1, with both 1-tailed and 2-tailed p-values affected by the
removal of the outlying record. In the original analysis (Figure 2), both p-values
indicated that asymmetry existed and after removing the record (Figure 3) the pvalues indicated that symmetry does exist (p>0.05)
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Table 1. Egger’s Regression Intercept and p-value scores for the Egger’s test of the
funnel plots with and without the outlier.
For all records
(Figure 2).

Omission of outlier
(Figure 3).

Intercept

63.239

-11.604

Standard Error

17.267

7.722

95% CI lower limit (2
tailed)

15.297

-36.180

95% CI upper limit (2
tailed)

111.180

12.972

t-value

3.662

1.503

df

4.000

3.000

p-value (1-tailed)

0.011

0.115

p-value (2-tailed)

0.022

0.230

The results from the meta-analysis including Whincup et al. (1995) can be seen in
Table 2 while Table 3 displays the results from the meta-analysis omitting it.
An I2 value of 99.4 was calculated and as it was greater than 75% it was determined
that a mixed-effects model was appropriate, because, as noted by Fernandez & Tran
(2009) mixed-effects models are usually reserved for I2 scores of greater than 75%.
As displayed in Table 2, p-values indicate significant results from the Barker et al.
(1990) and Whincup et al. (1995) records. One other record, Moore et al. (1996), had
a p-value of 0.05. All three cohorts from the Blake et al. (2001) record are not
significant.
In this analysis (Table 2), the combined effect favoured a lighter placenta, indicating
that higher blood pressure was related to a lighter placenta (Effect size = 0.250; pvalue<0.0005). An outlier (Effect size = 4.125; p-value<0.0005) which distinctly
favoured a lighter placenta (Whincup et al., 1995) was noted.
Once the outlier was removed, the analysis was re-run. Removing the outlier
generated an I2 value of 55.5, and as it was greater than 25% it was determined that
a mixed-effects model was appropriate, however, it is not greater than 75% and
therefore an analysis was run using both fixed and random effects models. The
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results are displayed in Table 3 and no difference was found between the fixed and
random effects models in the calculated results.
As displayed in Table 3, the effect sizes and p-values for indivudal studies remained
the same as in Table 2. P-values indicate significant results from the Barker et al.
(1990) and Whincup et al. (1995) records. The Moore et al. (1996) study retained the
p-value of 0.05 and all three cohorts from the Blake et al. (2001) record are not
significant.
The combined effect however, is no longer significant and has changed to indicate
that a higher blood pressure is related to a heavier placenta (Effect size = -0.044; pvalue = 0.24).
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Table 2. Results of the meta-analysis performed. Blake et al. (2001) included subjects from three age categories and therefore each age
category was treated as an individual cohort. Standard Difference in Means, Standard Error, Variance and Relative Weights were calculated
and Lower and Upper limits are reported for 95% CI. The plot shows that overall the condition favours a lighter placenta, indicating that higher
blood pressure is related to a lighter placenta.
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Table 3. Results of the meta-analysis omitting the outlier (Whincup et al. (1995)), performed on 3 records. Blake et al. (2001) included subjects
from three age categories and therefore each age category was treated as an individual cohort. Standard Difference in Means, Standard Error,
were calculated and Lower and Upper limits are reported for 95% CI. The plot shows that overall the condition favours a heavier placenta,
indicating that a higher blood pressure is related to a heavier placenta although it is not significant.
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To further understand the quality of the research articles being assessed and further
evaluate the removal of the outlier, an additional analysis of the quality of the studies
was undertaken.
The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was employed
and the results of the ranking are displayed in Figure 4. Of the 26 records ranked, 20
(77%) were of good quality, three (12%) were ranked as borderline Good/Fair and
another three were ranked as borderline Fair/Poor.
The borderline Good/Fair ranking was used as these three records received only 1✯
in the Outcome domain (placing them in the Poor Category), however, they received
sufficient scores in the other two domains to place them in the Good category. This
meant that they were in the Good category for two out of three domains, but placed
in the Poor category for one domain. Similarly, the Fair/Poor ranking was used
because the three records in this category received 3✯ in the Selection Domain
(placing them in the Good Category) and 1✯ in both the Comparability and Outcome
Domains, which places them in the Poor Category.
The Whincup et al. (1995) article which was originally identified as an outlier was one
of two articles that received the highest possible score (nine out of nine ✯),
therefore, it is not likely that it was an outlier or an error. The other records in the
meta-analysis are not as highly ranked, with Barker et al. (1990) scoring 8✯, Moore
et al. (1996) and Blake et al. (2001) both scoring 6✯. The other article which scored
9✯ (Risnes et al., 2009) found that death by CVD had an increase in HR per SD
(120g) of placental weight (HR 1.13, 95% CI 1.00, 1.28). Death by CHD had an
increase in HR per SD (120g) of placental weight (HR 1.13, 95% CI 0.97, 1.33) and
death by stroke Death had a decrease in HR per SD (120g) of placental weight (HR

54

0.083, 95% CI 0.87, 1.58). Therefore, the two highest ranked studies, both with 9✯,
found diverging associations between placental weight and cardiovascular health.
Selection

Authors
Whincup et al.
(1995)
Risnes et al. (2009)
Barker et al. (1990)
Barker et al. (2009)
Eriksson et al.
(2011)
Eriksson et al.
(2000)
Fan et al. (2009)
Hesmati & Koupil
(2014)
Leon et al. (1998)
Taylor et al. (1997)
Eriksson et al.
(2010)
Barker (1997) *
Burke et al. (2004)
Barker et al. (1992)
Campbell et al.
(1996)
Forsen et al. (1997)
Martyn et al. (1994)
Law et al. (1991)
Martyn et al. (1996)
Forsen et al. (1999)
Whincup et al.
(1999)
Blake et al. (2001)

Design
CH
CH
CH
CH

✯
✯
✯
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✯
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✯
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✯

✯

✯

✯
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✯

✯

✯
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✯
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✯
✯

✯
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✯
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✯
✯
✯
✯
✯
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✯

✯

✯

✯

✯

✯

✯

✯

✯

✯

✯

✯

✯
✯

✯

CH

Moore et al. (1999)
Winder et al. (2011)
Forrester et al.
(1996)

✯
✯

✯

✯

✯

✯

CH

✯
✯

✯

✯

✯

✯

CS

Moore et al. (1996)

✯

✯

✯

CH
CH
CH
CH
CH
CH

✯

✯

✯

CH

CH
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mpa
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lity

✯

✯

✯

✯
✯
✯
✯
✯
✯

✯

✯

✯
✯

✯
✯
✯

✯

Outcome

✯
✯
✯
✯
✯

✯
✯
✯
✯
✯

✯

Total

✯

9

✯

9
8

✯
✯

8

✯

✯

✯

8

✯

✯

✯

8

✯
✯
✯
✯

✯
✯
✯
✯

✯
✯
✯

8
8
8
7

✯

✯

7

✯

✯

7
7

✯
✯

✯
✯

✯

✯

✯
✯
✯
✯

✯
✯
✯
✯

✯

✯
✯

✯

✯

✯

✯

7
7
7
7
6
6
6
7
6

✯

6

✯

5

✯
✯

Quality
Good Quality
Selection: 3 or 4 ✯
Comparability: 1 or
2✯
Outcome: 2 or 3 ✯

5
5

Good/Fair Quality.
Selection: 4✯
Comparability: 1 or
2✯
Outcome: 1✯
Fair/Poor Quality:
Selection: 3✯
Comparability: 1✯
Outcome: 1✯

Figure 4. All 26 articles from the qualitative synthesis ranked from highest quality (9✯), to
lowest quality (5✯). The Newcastle Ottawa Scale (NOS) the Quality Assessment Form for
Cohort Studies.
Note: A study can be given a maximum of nine stars across the three sections of Selection,
Comparability and Outcome. The Agency for Healthcare Research and Quality (AHRQ) has
indicated that there are three standards, Good, Fair and Poor. These are defined as Good
quality: 3 or 4 ✯ in selection domain AND 1 or 2 ✯ in comparability domain AND 2 or 3 ✯ in
outcome/exposure domain. Fair quality: 2 ✯ in selection domain AND 1 or 2 ✯ in
comparability domain AND 2 or 3 ✯ in outcome/exposure domain. Poor quality: 0 or 1 ✯ in
selection domain OR 0 ✯ in comparability domain OR 0 or 1 ✯ in outcome/exposure domain.
One article, Barker (1997), indicated with an asterix (*) was ranked but it reported on data
previously published and so was not counted as an original article.
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3.3

Records Related to Blood Pressure: Qualitative Synthesis.

To further understand the relationship between placental weight and CVD outcomes,
the studies related to each outcome were analysed separately. Of the 26 records, 12
focused on blood pressure, of which four (Barker et al., 1990; Whincup et al., 1995;
Moore et al., 1996; Blake et al., 2001) were compatible for the meta-analysis. In this
group of 12, two reported mean diastolic and systolic blood pressures (DBP and
SBP), four reported mean SBP only (two reported group SD only and they were
found to be reporting on the same cohort, the duplicate article is indicated with an *
in Table 4) one used a calculation of mean difference and one reported incidence of
diagnosed hypertension, one record reported only a p-value for linear trend while no
records used DBP exclusively. In addition, there are four records which used either
SBP or DBP as a factor in regression model analysis. These records are listed along
with key information such as the placental weight categories used, direction of
relationship and p-value for linear trend (where reported) in Table 4. Five records
(42%) reported a positive relationship between placental weight and blood pressure
(i.e. the condition favours a heavier placenta or a heavier placenta is associated with
higher blood pressure). Four (33%) reported a negative relationship and two were
mixed, with Winder et al. (2011) reporting a positive relationship for girls and a
negative relationship for boys, conversely, Taylor et al. (1997) reported a negative
relationship for girls and and a positive one for boys. One article was the duplicate
study indicated with a asterix.
Of the four records which reported mean SBP and DBP, one record reported the
mean and a group standard deviation for the entire cohort, another record reported
means only without standard deviations or confidence intervals or a similar statistic.
One did not report any data but provided a descriptive statement on the relationship
between placental weight and blood pressure. Two records split the cohort to
compare boys and girls, one used means and standard deviations of SBP and DBP
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and the other used regression modelling with SBP and DBP as factors. Table 4
displays more detail for each study such as the reported regression coefficients, pvalues and direction of relationship.
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Table 4. Results of literature search. Articles listed have reported both placental weights and an association with blood pressure. Placental
weight categories, mean Systolic Blood Pressure (SBP), mean Diastolic Blood Pressure (DBP), direction of relationship (positive trend denotes
an increase in blood pressure between lightest to heaviest placental weight categories), p-values for linear trends are listed when available in
the published article. In some cases, SD, R2 and 95% CI were available and this has been noted in the table below. Of the twelve articles, five
articles demonstrated a positive relationship, four demonstrated a negative relationship, two articles examined boys and girls separately, one
found a negative trend for girls and a positive trend for boys, the second found a negative trend for girls DBP, boys SBP and DBP and a
positive trend for girls SBP, the remaining article shared data from another study indicated with *.
Authors
Blake et
al. (2001)

Moore et
al. (1996)

Placental Weight Measure (SBP, DBP or
categories
both)
Mean SBP (95% CI)
1 yo
3 yo
6 yo
<540g
98.3
99.6
104.3
541-640g
97.9
99.1
104.8
>640g
97.2
99.0
104.8

≤500g
510-600g
>600g

Mean SBP and DBP at age
8 no SD reported
SBP
DBP
100.6
60.1
101.5
60.7
102.2
62.3

Direction of
relationship
All regression
coefficients for
placental weight
and SBP were
negative.

P-value for
linear trend
None reported

Positive (SBP &
DBP)

None reported
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Other measures/ statements
The child’s current weight was the
concurrent variable most strongly
correlated with blood pressure.
Placental weight was positively
associated with current weight.
No consistent pattern was seen in the
relationship between placental weight
and SBP within birth weight groups or
overall. The highest SBP at age 6 years
was in those children with the highest
placental weight and lowest birth weight
and the lowest SBP was in those with
the lowest placental and highest birth
weight
Placental weight alone was not related
to systolic pressure. There was a
positive but not statistically significant
relationship between placental weight
and diastolic pressure.

Barker et
al. (1990)

Barker et
al. (1992)

Barker
(1997) *

Placental weights
in pounds
(converted to
grams)

RR SBP>160 mm Hg and RR
Treatment for Hypertension
SBP >160
Treatment for
mm Hg
Hypertension

≤1.0 (≤454g)
1.01-1.25
(458.54-567.5)
1.26-1.5 (572.04681)
>1.5 (>681)

1.0 (ref)
1.3

1.0 (ref)
1.1

2.4

1.2

3.0

2.5

Placental weights
in pounds
(converted to
grams)

Mean SBP group SD 20.2
age 46-54

≤1.0 (≤454g)
1.01-1.25
(458.54-567.5)
1.26-1.5 (572.04681)
>1.5 (>681)
Same cohort and
data as Barker
(1992)

144
148

Positive

None reported

Positive

None reported

148
156
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Systolic and diastolic blood pressure
were strongly related to placental
weight.
Mean differences were also calculated
with 95% CI
1st cohort Mean difference pw ≤1.5 lb
and >1.5 lb, 11 mm Hg, 4 to 18)
2nd cohort 7, 0 to 14
Combined 9, 4 to 14
The highest pressures were among
people who had been small babies with
large placentae and the lowest were
among people who had been large
babies with small placentae.

Law et al.
(1991)

Winder et
al. (2011)

Mean difference SBP mm Hg
and 95% CI age 4 years.
≤550g
650g
750g
>750g

≤350g
400g
450g
>450g

0 (ref)
-0.1
0.6
2.6
Mean SBP and DBP and SD
Age 9.5 yr
Boys
Girls
SBP
DBP SBP
DBP
102.5 58.5 99.4
58.6
101.1 58.7 99.6
58.6
103.6 59.4 100.1 57.9
100.6 57.5 100.6 56.6

Positive

None reported

Negative (Boys –
SBP and DBP,
Girls DBP)

0.15 (Boys
SBP)

Positive (Girls –
SBP)

0.24 (Boys
DBP)
0.8 (Girls SBP)

Burke et
al. (2004)

None used

Regression Modelling age 8
years
Coefficient 0.003
95% CI -0.001, 0.007

Positive

0.02 (Boys
DBP)
0.169

Campbell
et al.
(1996)

None used

Regression modelling
Statement only

Negative

0.2
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Length, breadth and area of placenta.

R2 0.001

Low placental weight was associated
with a higher blood pressure in the
offspring though this was not
statistically significant(regression
coefficient -9.2 mm Hg/kg; 95% CI 22.6 to 4.1

Taylor et
al. (1997)

None used

Regression modelling SBP
and DBP boys and girls 8-11
yr
Girls
Boys
SBP
DBP
SBP DBP
-7.74
-1.79
4.27 3.21

Negative (Girls)
Positive (Boys)

0.01 (Girls
SBP)
0.37 (Girls
DBP)

Difference in coefficients between boys
and girls
P value 0.002 (SBP), 0.05 (DBP)

0.09 (Boys
SBP)
0.05 (Boys
DBP)

Whincup
et al.
(1995)

Whincup
et al.
(1999)

Mean SBP and SE age 911yr
Low ≤589g
Middle 590 –
689g
High ≥690g

108.6
105.6

None used

Regression Modelling SBP
and DBP SE and p value
SBP
Coefficient -0.007
SE 0.003
p value 0.01
DBP
Coefficient -0.005
SE 0.002
P value 0.02

Negative

105.3
Negative

0.01 (SBP)
0.02 (DBP)
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Effect of adjustment for birth weight
examined

3.4

Records Related To Mortality or Morbidity.

Of the 26 records inspected, ten investigated the association between placental
weight and the risk of mortality by coronary heart disease (CHD), ischaemic heart
disease (IHD), stroke, cardiovascular disease (CVD) and diagnosed hypertension.
Table 5 lists these records and provides further details along with key information
such as the placental weight categories used, measure of risk (e.g. odds ratio),
direction of relationship and p-value for linear trend. Of the ten records, three used
hazard ratios (HR), three used odds ratios (OR), two used standardised mortality
ratios (SMR), one used a rate per 100,000 of population and one used cumulative
incidence (percentage). Three records (30%) focused on diagnosed hypertension,
one record observed the risk of death by stroke, CHD, and non-CVD causes, four
records focused on CHD, one used CVD and one used IHD. Of the ten records in
this section, six (60%) reported a negative relationship between placental weight and
mortality and morbidity (i.e. a lighter placenta is associated with an increased
mortality risk), three (30%) reported a positive relationship (i.e. a heavier placenta is
associated with increased mortality risk) and one (10%), Martyn et al. (1996), had
mixed results, reporting a negative relationship for stroke, and a positive relationship
for CHD and for non-CVD related deaths.
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Table 5. Results of literature search. Articles listed have reported both placental weights and an association with cardiovascular morbidity and
mortality. Placental weight categories, measure of cardiovascular morbidity and mortality such as odds ratio (OR), hazard ratio (HR),
standardised mortality ratio (SMR), risk ratio (RR), direction of relationship (positive trend denotes an increase in risk between lightest to
heaviest placental weight categories and a negative denotes a decrease in risk between the lightest to heaviest placental weight categories), pvalues for linear trends are listed when available in the published article. In some cases, SD, R2 and 95% CI were available and this has been
noted in the table below. Of the ten articles, three articles showed a positive relationship, six showed a negative relationship and Matryn et al.
(1996) demonstrated a negative result for stroke but a positive result for coronary heart disease.
Authors
Eriksson
et al.
(2011)

Barker
et al.
(2009)

Fan et
al.
(2009)

Placental Weight
categories

Measure (eg OR, HR, RR, SMR)

Direction of
relationship
Negative

P-value for
linear trend
0.1

≤550g
650g
750g
>750g

HR for coronary heart disease
1.2
1.1
1.3
1.0 (ref)

≤550g
650g
750g
>750g

OR for diagnosed hypertension
1.8
1.3
1.3
1.0 (ref)

Negative

<0.001

<450g
560g
670g
≥675g

OR for coronary heart disease
1.0 (ref)
0.69
0.5
0.47

Negative

0.05
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Other measures
In men whose mother’s BMI
was above the median,
coronary heart disease was
associated with low placental
weight and small placental
area.
Diagnosed hypertension
OR increased as placental
weight, area and the two
diameters decreased.
Hypertension was associated
with both reduced placental
weight and with increased
placental weight in relation to
birth weight.
Subjects with CHD had lower
birth-weight, placental weight,
birth length, smaller head
circumference, and birthweight/length.
Placental weights were low,
17.8% weighed less than 450g

Eriksson
et al.
(2010)

Risnes
et al.
(2009)

Hesmati
& Koupil
(2014)

≤550g
650g
750g
>750g

Lowest - Median
560g
Middle - Median
680g
Highest - Median
800g

≤550g
650g
750g
>750g

OR for diagnosed hypertension
Men
Women
1.6
2.0
1.1
1.6
1.2
1.3
1.0 (ref)
1.0

Negative

0.06 (Men)

HR for cardiovascular disease

Positive

0.04

Negative for
all categories.

95% CI
reported.

<0.001
(Women)

1.0 (ref)

OR per 100g
0.89 (Men)
0.80 (Women)
Mean birth weight and
placental weight were higher in
boys.
Hypertension in men was only
weakly related to low placental
weight.
Women with low placental
weight and area were at
increased risk.
Birth weight included as a
covariate in analysis of
placental weight.

0.97
1.35
Rates per 100,000 for Ischaemic Heart
Disease
Men
1344
1320
1249
1232

Women
799
705
711
682
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Negative trend found for both
men and women.
4 multivariate models
investigated

Eriksson
et al.
(2000)

Forsen
et al.
(1997)

Forsen
et al.
(1999)

Cumulative incidence (%) of hypertension
(use of medication)

0.07 (Men)
0.91
(Women)

No statistically significant trend
with placental weight and
cumulative incidence of
hypertension.

0.16 (All)

≤450g
550g
650g
750g
>750g

Men
30.7
28.8
25.4
27.0
24.6

≤500g
600g
700g
>700g

SMR for coronary heart disease
111
98
76
67

Positive

0.004

HR for coronary heart disease
No data reported.
Statement only

Positive

Statement
only
Trend was
not
significant.

≤500g
600g
700g
>700g

Women
28.3
27.8
28.5
30.1
27.3

Negative for
all categories.

All
29.5
28.3
26.9
28.5
25.8
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Ponderal index was strongly
associated with placental
weight. Men who had a low
placental weight had a low
ponderal index at birth and
raised death rates from
coronary heart disease as
adults.
Hazard ratios tended to rise
with increasing placental
weight, although this trend was
not significant. There was,
however, a significant rise with
an increasing ratio of placental
weight to birth weight (P=0.01,
adjusted for gestation). In a
simultaneous analysis with
birth weight, placental weight,
and gestational age the hazard
ratios fell with increasing birth

Martyn
et al.
(1996)

Placental weights
in pounds
(converted to
grams)
≤1.0 (≤454g)
1.01-1.25 (458.54567.5)
1.26-1.5 (572.04681)
>1.5 (>681)

SMR for stroke, CHD and non-CVD causes
Stroke
CHD
Non-CVD causes

Negative
(Stroke)

147

93

101

Positive
(CHD)

125

108

103

96
100

97
106

106
103

Positive (nonCVD causes)
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Not stated.

weight (P=0.007) but rose with
increasing placental weight
(P=0.03). There were stronger
trends in a simultaneous
analysis of birth length,
placental weight, and
gestational age, the hazard
ratios falling with increasing
birth length (P>0.0001) and
rising with increasing placental
weight (P=0.02). The hazard
ratios increased by 13.8% (7.5
to 19.6) for each cm decrease
in length at birth and increased
by 14.8% (2.6 to 28.3) for each
100 g increase in placental
weight. The trends with length
and placental weight were
similar for fatal and non-fatal
disease.
U shaped variation noted.
5% of the population died from
stroke, 35% died from
coronary heart disease.

3.5

Records With Defining Statements But No Data.

There were four records found through the search which made defining statements
on the relationship (or lack of) between placental weight and either blood pressure or
death by IHD. Table 6 lists the four records along with key information such as the
defining statement. One record reported no evidence of an association between
placental weight and mortality from IHD and three records reported on the
association between placental weight and blood pressure. Of the three records
reporting associations with blood pressure, one indicated no consistent relationship
between placental weight and SBP or DBP, another reported that the placental
weight was not associated with SBP, but had a correlation with DBP (r=0.12,
p=0.05). The last record reported that an inverse relationship between SBP and
placental weight existed (p=0.003) after adjustment for age, sex and current weight
and this became non-significant in a simultaneous regression with birth weight.
Therefore, it was deemed non-significant.
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Table 6. Results of literature search. Articles listed have not reported any data.
Authors made a summary statement of the relationship in the text of the article.
Authors
Leon et
al.
(1998)
Martyn
et al.
(1995)

Placental
Weight
Categories
Not
reported

Measure
used

Statement

Data not
shown

Not
reported

Data not
shown
SBP and
DBP age 5053 yr
Data not
shown SBP
DBP age 20
yr

There was no evidence of any
association of placental weight with
mortality from ischaemic heart disease.
No consistent relationship between adult
blood pressure and placental weight or
ponderal index (weight/length3) of the
infant for either systolic or diastolic
pressure found.
Placental weight was not associated
with systolic pressure when considered
alone.
Placental weight was correlated with
DBP (r=-0.12, p=0.05) which did not
persist after adjustment for gestational
age.
Placental weight was inversely related
to systolic pressure after adjustment for
age, sex, and current weight (test for
trend p=0.003) This relationship became
non-significant in a simultaneous
regression with birth weight.

Moore et
al.
(1999)

Not
reported

Forrester
et al.
(1996)

Not
reported

Data not
shown SBP
age 6-16
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3.6

Characteristics of The Studies.

To further investigate the nature of these studies a range of characteristics that may
influence the findings have been explored. Figure 5 displays the various
characteristics of the records included in this study. Note that a total of six records
are not included in Figure 5, these include the four records reported in Table 6. The
other two records do not appear in this figure because they were either a record that
measured placental weights and only related it to exposure to famine (Roseboom et
al., 2011) and a record which measured placental weights and used them in a cluster
analysis of Percentage of Expected Birth Weight (Huang, et al., 2007) or did not
explicitly report any data.
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Key Measrue Reported

DBP

0

Cluster Analysis

1

Cumulative Incidence (%) of hypertension

1

Mean Difference (95% CI)

1

Standard Mortality Ratio

2

Hazard Ratio (Mortality)

3

Regression Model

4

Diagnosed Hypertension

4

Defining Statement

4

DBP & SBP

4

Odds Ratio (Mortality or diagnosed hypertension)

6

SBP

7

Relative Risk (SBP and treatment for hypertension)

12
0

1

2

3

4

5

6
7
Number Of Articles

8

9

10

11

12

13

Figure 5. Different types of cardiovascular characteristics reported in the articles found. A score of 1 was allocated to each key measure e.g. a
record that reported SBP and used a regression model would contribute a score of 1 to both the regression model and the SBP key measure.
Note: the four records reported in Table 6 do not appear in this figure.
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3.7

Age of Participants.

The participants studied in the various records found ranged from 1 year to 69 years of age, Figure 6 graphs the range of ages, a score or 1
was given to each age category reported e.g. if the record stated that the cohort was between 6 and 16 years of age, then a score of 1 was
allocated to each year from 6 through to 16. Although the range was from 1 year to 69 years of age, there appears to be a gap in the data
available for participants 21-36 years, where there were no studies with any participants in that age range.

Number of records

7
6
5
4
3
2
1
1

3

5

7

9

11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59 61 63 65 67 69

Figure 6. Age of participants in the 26 records identified.

Age of participants

Note: A score of 1 was allocated to each age category reported in the record such that a record stated that the cohort was between
6 and 16 years, a score of 1 was allocated to each year from 6 through to 16.
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3.8

Geographical Focus

A geographical analysis of the 26 records is displayed in Figure 7, as a heat map of the world.The records clustered around specific areas of
the world, namely the United Kingdom (10 records), followed by Finland (5), Australia (4) and Sweden (2). China, India and Norway all had 1
record each. The studies anaylsed in the meta-analysis focused on cohorts from the United Kingdom (Barker et al., 1990; Whincup et al., 1995)
and Australia (Blake et al., 2001; Moore et al., 1996).

Legend

Figure 7. Heat map displaying the locations of the 26 studies identified.
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4. Discussion.
Cardiovascular diseases are the leading non-communicable cause of mortality
world-wide. The early environment, particularly the intrauterine environment, has
been implicated as a risk factor and a potential target for intervention. However, the
role of the placenta in this relationship is poorly understood.
This study used meta-analytical techniques to explore the association between
placental weight and subsequent cardiovascular health outcomes in humans. The
initial search process detailed in Figure 1 identified 844 records. Of these, 26
records, providing 6 data points in total, were analysed.
The systematic review identified 26 records which matched the selection criteria and
these records had a combined cohort of 109,721 individuals, with 5,823 affected
individuals. Four records reported compatible data that was adequate to perform a
statistical meta-analysis (refer to Figure 4). Blake et al. (2001) reported data at age
1, 3 and 6 years of age and so each data set was treated as an individual study,
providing six data points in total.
The meta-analysis showed that a lighter placenta was associated with a subsequent
higher blood pressure. This association was greatly influenced by an outlier and
once removed, the combined effect reversed direction to favour a heavier placenta.
The only record which retained significance (p=0.034) was one of the original articles
written by Barker et al. (1990). The remaining records displayed an effect which is
not significant and very close to the line of no effect. This analysis suggests that the
evidence relating specifically to placental weight and CVD is much more diverse than
for birth weight. Currently a strong conclusion on the effect size cannot be made.
Importantly, this analysis brings the placental weight research into focus and
highlights methodological weakness, research gaps and future directions for study.
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4.1

Inspection of Funnel Plots, Meta-Analysis Results and
Outlier.

On examination of the first funnel plot, (Figure 2) a clear indication of a publication
bias related effect was noted, as there was a specific record (highlighted in red)
which did not sit in the boundary of the funnel plot. This visual observation was
supported by the Egger’s p-values of 0.01 (1-tailed) and 0.02 (2-tailed). The clear
outlier was removed and the plot re-drawn, with the resulting plot (Figure 3) being
more consistent with the type of plot that demonstrates symmetry, that is all the
records are plotted within the confines of the funnel plot boundaries. This is further
supported by Egger’s p-values<0.05 (0.011, 1-tailed and 0.022, 2-tailed) indicating
that publication bias was evident. The outlying record (Whincup et al., 1995) had
such a large impact on the funnel plot and combined effect size because its cohort
size was the largest of the records in this calculation (n=1,511 compared to n=1,039
for the next largest cohort) and therefore had more power in affecting combined
effect size. Additionally, removing this outlier influenced the I2 score (increasing it
from 55.5% to 99.4%) which firmly set it in the category of a mixed effects model as
it was above the 75% threshold prescribed by Fernandez & Tran (2009). In the
original meta-analysis, the outlier was seen to have an effect size of 4.125 compared
to the combined effect of 0.250 (as calculated by the Standard Difference in Means
in Table 2), which further highlights the magnitude of the effect of this specific record.
To gain a better understanding of the quality and reliability of these findings, the
effect of this outlier was investigated further using the NOS to examine and rank the
records. The outlier returned a maximum score of nine out of nine stars, indicating
that it was a high quality study. This score placed the outlier on par with a study by
Risnes et al. (2009), which was the only other record to score nine stars.
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Although the two studies measured different factors, Whincup et al. (1995) measured
SBP and Risnes et al. (2009) measured mortality, it is useful to compare their
findings. For Whincup et al. (1995) a heavier placenta was associated with a
decrease in SBP whereas Risnes et al. (2009) found that a heavier placenta was
associated with increased chance of death by CVD and CHD and a decreased
chance of death by stroke and this further highlights to complications with studying
the effect of placental weight on CVD, as increased SBP is noted as one of the risk
factors for all CVD.
Therefore, the high quality of the Whincup et al. (1995) article does support its
inclusion in the meta-analysis. However, its influence on the direction of the
combined effect and presence of publication bias indicate that there needs to be
more exploration of the data as well as unified reporting of the research which will
facilitate the inclusion of other studies into future meta-analyses.
Moreover, this raises the issue of which additional articles that were excluded should
be considered and contribute to the effect recorded.

4.2

Placental Weight and Blood Pressure and Sex.

Of the 12 records which examined placental weight and blood pressure, 5 reported a
positive relationship for the entire cohort studied, indicating that as placental weight
increased, so too did blood pressure (refer to Table 4 for further details). Four
records reported a negative relationship for the entire cohort studied, two records
split their cohorts into girls and boys and SBP and DBP. The remaining record
(Barker, 1997) is not included as it referred to a cohort already studied (Barker,
1992).
Fundamental physiological differences between the sexes indicate that there is a
need to examine the variation between sexes. Winder et al. (2011) and Taylor et al.
(1997) split their cohorts into girls and boys and measured both SBP and DBP.
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Winder et al. (2011) reported means and SD whereas Taylor et al. (1997) performed
regression modelling. Winder et al. (2011) identified a negative trend for boys (both
SBP and DBP) with the boys DBP being significant (p-value=0.02) and a negative
trend for girls SBP which was not significant (no p-value reported). Taylor et al.
(1997) identified a negative trend for girls (SBP and DBP) with only the girls SBP
trend being significant (p-value=0.01) and a positive trend for boys (SBP and DBP)
with only the boys (DBP) trend being significant (p-value=0.05). This variation
between males and females has been attributed to key differences in hormone
profiles, as demonstrated by experiments on IUGR rats where males showed
significantly higher blood pressures compared to the female IUGR rats (Dasinger &
Alexander, 2016). Here oestrogen is seen as a protective factor, which normalises
blood pressure and provides protection for females from CVD, conversely, the male
hormone, testosterone is seen as a cause for elevated blood pressure (Dasinger &
Alexander, 2016). This is reflected in the human population where men usually
display higher blood pressures and greater risk for CVDs than women of the same
age (Dasinger & Alexander, 2016; WHO, 2011). Therefore a separate analysis for
males and females may be necessary to clarify the relationship and may cancel each
other out in studies that are included in the current meta-analysis.
Two of the most influential articles in the field of DOHaD which have been key
references in the formation of this paradigm observed cohorts of adult age: Barker et
al. (1990) and Barker et al. (1992). Barker et al. (1990), examined the Relative Risk
(RR) of having a SBP greater than 160mm Hg and the RR of being treated for
hypertension in doing so. The authors noted that SBP and DBP were strongly related
to placental weight and that the highest pressures were measured in people who had
been small babies with large placentae and conversely, the lowest pressures were
measured in people who were large babies with small placentae (Barker et al.,
1990). The second record, Barker et al. (1992), similarly found a positive trend with
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mean SBP and placental weight although no significance measure was reported.
The Barker et al. (1990) article noted that babies with placentae >1.5 pounds or
>681 grams (SI unit conversion 1 pound = 454g) had a greater RR of having a SBP
>160 mm Hg as well as a greater RR of being treated for hypertension than babies
with a placental weight of ≤1.5 pounds. In further support the Barker (1992) article
reported that babies with placental weights >1.5 pounds or >681 grams had higher
mean SBP in adult life. This further highlights the complexity of the relationship,
although, placental characteristics such as size, weight, volume and shape are all
factors in determining the efficiency of a placenta. Ultimately, it is the amount of fetus
which develops from a placenta that is the evidence of the efficiency of a placenta.
Thus it may be inappropriate to consider placental weight as a predictor of CVD in
isolation and it is its relationship with birth weight that provides more information.
However, although the placental weight to birth weight ratio may in turn be limited, it
is possible that a heavy placenta may be just as efficient as one of less weight
simply because it has the same surface area (Salafia et al., 2008; Eriksson et al.,
2011).

4.3

Placental Weight and CVD, CHD, IHD and Stroke.

Of the 10 records which examined the risk of developing or dying from CVD, CHD,
IHD and Stroke, six (60%) reported that a heavier placenta was associated with a
decreased chance of death. Of these six records, two reported that the linear trend
was significant, one reported that it was significant only for women, three records
reported a positive association and two indicated that it was significant. The last
record by Martyn et al. (1996) split the cohort into three groups, a stroke group, a
CHD group and a non-CVD group and they reported that a heavier placenta
decreased the risk of stroke, but increased the risk of death by CHD and non-CVD
causes. No p-values or any other measures of significance were reported although a
U-shaped variation was observed in this study (Martyn et al., 1996).
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When these studies are grouped by disease (e.g. diagnosed hypertension, CVD,
CHD, IHD), there were no consistent findings. The majority of the studies reported a
significant p-value for linear trend, however the direction of the relationship was
almost evenly divided between studies showing that a heavier placenta is associated
with decreased risk and a lighter placenta associated with increased risk.

4.4

Variation, Study Characteristics and Measured Outcomes.

It has been noted by the PRISMA group (2009) that variation in reporting does have
a negative impact on the usefulness of systematic reviews and meta-analyses. This
statement is clearly supported by the findings from the current study. In the 26
records identified, substantial variation has been apparent in the different methods of
reporting. Figure 5 highlights the numerous items reported including odds ratios,
hazard ratios and standardised mortality ratios. As well as the methods of measuring
placental weight, one record indicated that the placentae were fixed in formalin
(Whincup et al., 1999) compared to the other studies in which placentae are
measured in an unfixed state.
Outcomes (conditions) are also measured in different ways where some report only
the SBP while others used a diagnosis of hypertension, or treatment for CVD and
others only looked at mortality rates. Further to this variability there is the rate of
survival from a major CVD incident (e.g. myocardial infarction or stroke) or receiving
treatment.
In addition to these variations, there are physiological and anatomical variations of
the placenta, which is an organ that grows with the fetus and adjusts its growth
patterns to match the environment as well as the demands from the fetus. Variations
in the placenta can be affected by the environment through infections, anatomical
differences in the point of attachment on the uterine surface as well as the level of
remodelling of the spiral arteries. As the fetus develops, its nutritional demands are
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served through the placenta and this is maintained via a delicate balance between
growth of the fetus and growth of the placenta. Additionally, the fetal heart and the
placenta share common developmental requirements, such as common genes and
micronutrients (e.g. folate) regulating essential developmental steps (Burton &
Jauniaux, 2018). Considering these factors, no two placentae should be alike,
therefore, it is all the more important to systematically select and process placental
measures in the future to standardise this field (Salafia & Roberts, 2019).
A key difference in the reporting and comparison of placental weights is the weight
categories used by researchers. In summary, across all the records found, there was
a broad range in the placental weights studied with the lightest placental weight
group being ≤350g and the heaviest >750g (there was another study reporting the
highest group with a median placental weight of 800g). To further complicate
matters, Barker et al.’s (1986, 1990, 1993) earlier work utilised imperial pounds as
the standard measure and the lightest placental weight group was ≤1 pound or
≤454g and the heaviest group was >1.5 pounds or >681 grams (SI unit conversion 1
pound = 454g).
The cohorts studied were regularly divided into groups according to placental weight.
Aside from the four records which made defining statements and the four records
which used regression modelling, all other records (18), divided the cohorts into
groups according to placental weight. The number of groups ranged from three to
five with the most common being four groups (13 records). Of these 13 records that
used 4 placental weight categories, the largest placental weight group was >750g
and the smallest was ≤550g. Only one record used 5 placental weight groups, in this
record, a ≤450g group was added to accommodate the lightest placentae in that
study. Only one record reported median placental weight for the groupings and there
were three groups in this record (Lowest group: median placental weight 560g;
Middle group: median placental weight 680g; Highest group: median placental
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weight 800g). The variety in these categories impacted on the ability to find
comparable data to carry out a comprehensive meta-analysis. A more uniform
reporting of this data would improve the comparability of the data for meta-analysis.
Alternatively, if raw data sets were obtained, it may be possible to perform metaregression analysis on these data sets as a whole in a similar way that Gamborg et
al. (2007) used birth weights and systolic blood pressures from 20 Nordic studies.
This variance in placental weights, particularly the proportion of low weight
placentae, was noted by Fan et al. (2009) as 17.8% of all placentae in their study
(total n=2033) weighed less than 450g. More strikingly, Winder et al. (2011) studied
a cohort where 74.9% of all placentae weighed less than 450g (total n=471). By
contrast, Eriksson et al. (2000) reported figures showing only 7.2% of placentae in
the same weight category (total n=7086). Exploring the mean weights of placentae,
we find that in Fan et al. (2009) the mean placental weights were 539.1g ± 103.1g
(n=928 men) and 525.7g ± 101.8g (n=953 women). Winder et al. (2011) reported
mean placental weights for boys (n=228) of 410g (SD=81g) and 407g (SD=85g) for
girls (n=243). At the opposing end of the scale, Forsen et al. (1997) reported the
heaviest mean placental weight of 634g (SD=128g) and a placental weight range for
men from 240g to 1440g (n=3302). Comparably, a study of 513 placentae found a
mean placental weight (trimmed) of 538.3g (SD=95.3g) which was closer to Fan et
al.’s (2009) cohort and a range of 261g to 877g (Coall et al., 2009).
In addition, the methodology used to weigh the placentae can make significant
differences. Due to a range of factors, there has been measurement errors in the
past, and even in the current research, uniform weighing of placentae within and
between studies were not present, a key factor influencing placental weight being the
time from birth to weighing of the placenta. (Coall et al., 2009).
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It can be seen that extremes of placental weight exist in the various cohorts studied
and unlike birth weight where 2.5 kg is seen as a critical cut off, there is no cut off for
placental weight. Records which attempted to evenly distribute the cohort into groups
were required to make arbitrary decisions on the groupings based on no defining
evidence on what an adequate weight for a placenta is. This lends weight to the
notion that placental weight cannot be used in isolation when examining its effects
on cardiovascular outcomes of the baby until standardised advances in methodology
have been agreed upon. Further investigation into what a ‘standard placenta’ is and
a better understanding of what placental weight represents is essential for this
research to progress.

4.5

Age of Participants.

As shown in Figure 5, the age range of participants was from 1 to 69 years old.
There was, however, a gap between 21 and 36 years of age where there were no
records found focusing on people of that age. It is understood that there is a paucity
of information in that age bracket as it is an age group in which CVD is not seen as a
major risk and deaths caused by CVD are rare and usually attributed to unusual
circumstances. Likewise, hypertension and blood pressure in general is not a key
concern for people in that age group and so it is not a widely studied factor. When
considering age, it is also important to consider that the protective nature of
oestrogen does diminish as women reach menopause and oestrogen production
slows (Dasinger & Alexander, 2016). This variation and the underlying assumptions
related to the relatively healthy age group may contribute to a lack of research in this
age group.

4.6

Geographical Focus

When the records were compared according to country of focus, it was found that
38.5% (n=10) of the records focused on cohorts in the United Kingdom, followed by
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19.2% (n=5) for Finland, 15.4% (n=4) for Australia, followed by 7.7% (n=2) for both
Sweden and the West Indies (Jamaica), and 3.8% (n=1) for China, Norway and
India. It is important to note that although Norway had one record, it was the largest
of all the cohorts studied (n=31,307).
The most prolific author was Barker, who appeared in 12 records (46.2%), six
focusing on cohorts in the United Kingdom, all of the five records focusing on Finland
and the one record that focused on India.

4.7

NOS Analysis of Quality.

As the present study was not able to complete a comprehensive meta-analysis of the
records identified, it was recognised that a tool to assess the quality of the articles
should be employed to further investigate these results. The NOS scale was used to
provide further analysis of the quality of the records found as it was previously used
to investigate the outlier which was ranked the equal highest with the maximum
score (nine stars). The remaining records in the meta-analysis scored eight stars
(Barker et al., 1990) and six stars (Blake et al., 2001) and (Moore et al., 1996). This
indicates that the studies included in the meta-analysis were of Good quality.
Further analysis of the records showed that the mode and median score were both
seven stars and the mean was 6.9 stars (SD 1.1) with the range of scores from five
to nine stars. There were three records scoring the lowest (five stars) which
according to the AHRQ is a fair quality study. These articles were lacking in the
‘Selection’ domain under the “Representativeness of the Cohort” as they were
subsets of larger cohorts such as in the Winder et al. (2011) study in which eligible
participants attended the antenatal clinic at the Holdsworth Memorial Hospital in
Mysore, South India and they didn’t have diabetes before pregnancy. In addition,
there was a 67% uptake by the eligible parties. Likewise, Moore et al. (1999) focused
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on the cohort born at a single (unnamed) hospital in Adelaide, South Australia,
furthermore, there was a 72% participation rate.
The ‘Outcome’ domain was another domain in which these records scored poorly
(scoring one out of a possible 3 stars). It is noted that the adequacy of follow up may
be a reflection of low participation rates as other studies with higher participation
rates scored better in this domain. Finally, in the ‘Comparability’ domain, these three
records failed to satisfy the criteria “Adjustment for age, sex and marital status”,
which was not a key issue as only three records were able to satisfy this.
The ‘Outcome’ domain was the domain which saw the greatest variability with the
highest ranked records achieving a full 3✯ and the lowest ranked records achieving
1 out of 3✯, which was due to the impact of lower levels of follow up rates. Despite
this the records achieved a mean of 6.9✯ (SD1.1), which indicates how important
complete and accurate data recording, as well as good follow up practices are, when
conducting this research as those three articles ranked as Fair quality, would have
been ranked as Good if the follow up rates were improved. All ten articles reporting
rates of mortality and morbidity due to CVD were ranked in the Good category, and
although 60% of the articles found a negative association, there was one record
(Risnes et al., 2009) scoring the highest possible score of nine stars which found a
positive trend. To further highlight the inconsistencies, for the articles reporting on
blood pressure and hypertension, the highest ranked article (Whincup et al., 1995)
reported a negative association.

4.8

U shaped curve

A possible explanation of the inconsistent nature of the findings may be due to the
assumption made about the data and data analysis. It is evident that most articles
assume the association between measures of the uterine environment such as
placental weight and cardiovascular health is linear. However, because of the
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adaptive reserve capacity of the placenta, there is no reason to assume an
increasing placental weight is uniformly positive or negative. Therefore, it is
important to explore curvilinear, particularly quadrilateral relationships.
Theoretically, the u-shaped curve association between the early environment and
cardio-vascular health is likely to exist. In a study of 15,324 children, where SBP was
measured, both the lower birth weight group (<2,000 g) and the higher birth weight
group (3,500–3,999 g) and the highest birth weight group (>4,000 g) exhibited
significantly higher SBP when compared to the median weight group (2500–2999 g)
(Lai et al., 2019). The median birth weight group had the lowest SBP (103.56±0.23
mm Hg) and was set as the reference group, the lower birth weight group had a
mean SBP of 106.00±0.72 mm Hg (p=0.017), and the higher birth weight group had
a mean SBP of 105.13±0.17 mm Hg (p<0.001). The highest group exhibited a mean
SBP of 105.96±0.27 mm Hg (p<0.001).
Moreover, there are recognised differences in male and female physiology which
indicate that the association in males could be different to that in females. In a study
using linear regression modelling, placental weight was shown to have a negative
association in girls and a positive association in boys for both SBP and DBP,
furthermore, the p values for differences in the regression coefficients (b) were see
to be significant (p=0.002 for SBP and p=0.05 for DBP) (Taylor et al., 1997).
However, the majority of studies found through this meta-analysis fail to examine or
do not report looking for this u-shaped relationship between placental weight and
CVD.
In Thornburg et al.’s (2010) review of the placenta’s role in programming subsequent
cardiovascular disease, a U-shaped relationship was said to exist between the
placental to fetal weight ratio and CVD. In the present study, one record, reported a
U-shaped variation when describing the association between placental weight ratio
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and risk of CVD (Martyn et al., 1996). Therefore, both a low and high placental
weight ratio are associated with an increased risk of CVD. Consequently, the risk
factor may not be the absolute birth weight or placental weight but the relative
weight. This may more accurately reflect the challenges of the early environment and
the placenta’s capacity to adapt to insults. The placenta can adapt morphologically
and functionally and these adaptations are a response to meet the demands of the
developing fetus (Sferruzzi-Perri & Camm, 2016). These changes may be seen in
changes to endothelial function, growth factors and angiogenesis that are then
related to CV health. This provides strong evidence that the growth regulating
abilities of the placenta may lead to reduced cardiovascular health in the offspring.
Therefore, future research and secondary data analysis should routinely explore the
curvilinear, in addition to the linear, associations between the early environment and
adult outcomes. Ultimately, this will advance the field and align the epidemiological
associations with the underlying biological evidence.
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5. Conclusion.
This study, through the meta-analysis of data points, found that a higher blood
pressure was associated with a lighter placenta (a combined effect of 0.25 with a pvalue <0.05). Due to the presence of an outlier, the analysis was repeated without
the outlier and the combined effect indicated that a higher blood pressure was
associated with a heavier placenta (combined effect of -0.044) but this was not
significant (p-value=0.24).
Through this process of systematically searching the literature and conducting a
meta-analysis, it has been shown that a large study such as that by Whincup et al.
(1995) can alter the results of a meta-analysis greatly. The findings from this project
further demonstrate the complexity of the field of study. There is a plethora of
variation including study designs, measured outcomes and reporting criteria which
may obfuscate the possible trends and observations. Further to this, the variety of
confounding variables which a study can adjust for demonstrates that placental
weight cannot be viewed in isolation. The field has moved towards more complex
measures of the placenta such as thickness, circumference and volume.
Furthermore, real time imaging of the placenta in-utero, as the fetus develops, will
contribute another dimension to our understanding.
Future studies require standardised reporting of variables and measured outcomes
as well as methodologies (e.g. standardised weighing of the placenta and reporting
of weight categories). It is also recommended that retrospectively, raw data should
be shared enabling the categorisation of variables to be matched and a large, more
accurate and inclusive meta-analysis may be conducted. There is a need for
uniformity in the data collection and analysis to enable a deeper understanding of the
association between the early environment, particularly placental measurements,
and the subsequent risk of adult disease.
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In addition, future studies should attempt to capture the missing age groups (21 – 36
years of age) and include them in the analysis of the effect of placental weight on
cardiovascular outcomes, this would further contribute to the field of research.

6. Limitations.
The author notes that the search concluded in 2017 and it has taken 17 months to
complete this thesis, therefore, it is possible that articles published after 2017 were
not included in this work. This was unavoidable, due to the nature of the full time
work commitments of the author. To the best of my knowledge no pertinent research
is available to include. However, it may be possible in future studies to redo the
search with stricter time limits and using an independent searcher to verify the
findings.
The systematic literature search itself was conducted by the author alone and it has
been recommended by the PRISMA group as well as the Cochrane group that
searches should be conducted in tandem at least for reliability. Information
technologists at the ECU library were contacted to assist and while their advice was
valuable, it was clear that it was an important factor, however, limited resources and
capabilities meant that this was not possible. As with all systematic reviews and
meta-analyses, the grey literature is a limitation. Every effort was made to search for
grey literature and to contact likely authors who had published related work,
however, communications to the corresponding authors were not successful.
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8. Appendix A Extracted Data From Records

Source

Eriksson, Kajantie,
Thornburg,
Osmond & Barker.
(2011) Mother's
body size and
placental size
predict coronary
heart disease in
men. European
Heart Journal
32:2297-2303

Setting/Cohort Recruitment
Studied
Location

Men Helsinki
Cohort, 1934-44

Details of birth
records from
University Central
Hospital or the
Maternity
Hospital in
Helsinki

Diagnostic
Age at
Criteria For
Method of
Cardiovascular Outcome
Measurement Disease
(Years)

Historical Medical
Records
HR (95% CI)

Death classified by
International
Classification of
Disease (ICD)
codes.

Not reported.
Data reports
death or
hospital
admission due
to coronary
heart disease
(ICD-8, ICD-9
and ICD-10).
96

Total Number
of Subjects
(Number of
subjects with
Cardiovascular
Effects)

6975(655)

Placental
weight
categories
Other placenta
(if
reported) data

≤0.55kg
0.65kg
0.75kg
>0.75kg

Key findings
related to
placenta

Three combinations
of maternal body size
and placental size
predict later coronary
disease in men. 1)
Oval placental
surface in short
mothers, 2) small
placental surface in
tall mothers whose
body mass index was
above the median. 3)
Large placental
surface in relation to
birth weight.
Men whose mother's
BMI was above the
median, coronary
heart disease was
associated with low
placental weight and
small placental area.
HR 1.25 (1.10-1.42,
P=0.0007) per 40
sqcm decrease in the
surface area.
Men whose mother's
BMI was below the
median coronary
heart disease was
Placental surface area related to a high ratio
of placental weight
Placental/birth
to birth weight and a
weight (%)
high ratio of
Placental length
minus breadth
placental area to

Comments

1934-44
Helsinki Cohort
Women were
excluded from
the analysis as
only 166 cases
of coronary
heart disease
were reported
in the cohort.

birth weight (p=0.02)
HR 1.07 (1.02-1.13,
P=0.01) per 1%
increase in the
placental
weight/birth weight
ratio.

Winder,
Krishnaveni, Hill,
Karat, Fall, Veena
& Barker. (2010)
Placental
programming of
blood pressure in
Indian children.
Acta Paediatrica
100; 653-660

Mysore Parthenon
Cohort est. 1997

Recruited from
Holdsworth
Memorial
Hospital, Mysore,
South India.

Annual follow up
(birth to 5 yr) and
every 6 months
therafter.
Mean and SD
reported

Diastolic and
Systolic blood
pressure at age 9.5
years.

9.5 years

97

471

≤0.35kg
0.4kg
0.45kg
>0.45kg

Placental surface area
Placental/birth weight
(%)
Area/birth weight

Three different
placental phenotypes
predicted raised
blood pressure
depending on the
child’s sex and the
mother’s height.
Common to each
phenotype was that
blood pressure was
related to the shape
or size of the
placental surface and
to the breadth rather
than to the length.

Focus is on
placental
surface area
and length vs
breadth. 3
Placental
phenotypes.

Heshmati &
Koupil. (2014)
Placental weight
and foetal growth
rate as predicators
of ischaemic heart
disease in a
Swedish cohort
Journal of
Developmental
Origins of Health
and Disease 5(3):
164-170

Barker,
Thornburg,
Osmond, Kajantie
& Eriksson. (2010)

Uppsala Birth
Cohort
Multigenerational
Study (UBCoS
Multigen), 19151929.

Historical Medical
Records from
Uppsala
University
Hospital, Sweden.

Subset of Helsinki
Cohort (Men and
Women) 1934-44.

University Central
Hospital and
infant welfare
clinics in the city.

Historical Medical
Records
HR (95% CI)

First recorded
hospitalization or
death from IHD,
using International
Classification of
Disease (ICD)
codes.

Historical Medical
Records
OR (95% CI)

Diagnosed with
hypertension and
been prescribed
medication.

Not reported.
Data reports
death or
hospital
admission due
to coronary
heart disease
(ICD-7, ICD-8,
ICD-9 and ICD10).

Not reported
98

10503

≤0.55kg
0.551-0.65kg
0.651-0.75kg
>0.75kg

≤0.55kg
0.65kg
0.75kg
2003(644) >0.75kg

Placental/birth weight
(%)

Placental surface
area. Maximal and
lesser diameters

Negative linear trend
was observed
between placental
weight and IHD after
adjustment for birth
cohort, age, sex and
parity, and the
association appeared
to be mediated by
fetal growth rate.
In the analysis
stratified by social
class at birth, a
negative association
between placental
weight and IHD was
observed among
individuals from
medium social class
after adjustment for
birth cohort, age and
sex. Similarly, a
negative association
between placental
weight and IHD was
found for individuals
who had a low
education.
Placenta/birth weight
ratio showed no
evidence of a
significant association
with IHD in our
cohort.
Hypertension was
associated with both
reduced placental
weight and with
increased placental
weight in relation to
birth weight. Both of
these associations
have been found
before (Barker et al,
1990; Campbell et al,
1996; Eriksson et al,
2000). The
association with low
placental weight was

accompanied by
reduced placental
area but not reduced
thickness.

Risnes,
Romundstad,
Nilsen, Esklid &
Vatten.
(2009)Placental
Weight Relative to
Birth Weight and
Long-term
Cardiovascular
Mortality:
Findings From a
Cohort of 31,307
Men and Women.
Am. J Epi
170(5)622-631
Burke, Beilin,
Blake, Doherty,
Kendall,
Newnham,
Landau & Stanley.
(2004) Indicators
of Fetal Growth
Do Not
Independently
Predict Blood
Pressure in 8Year-Old
Australians
Hypertension
43:208-213

Trondheim Cohort
1934-59

Raine Cohort 1989

St Olav's
University
Hospital
Trondheim
Norway.

King Edward
Memorial
Hospital, Perth,
Western
Australia.

Historical Medical
Records HR (95%
CI)

Historical Medical
Records
Regression
coefficient R2

Death classified by
International
Classification of
Disease (ICD)
codes.
Cardiovascular
disease, coronary
heart disease and
stroke

Systolic Blood
Pressure age 8 yr.

Mean age of
mortality 51.3
yr

8 yr.

Low Med
31307(382) and High

1417 Not Used

99

Placental/birth
weight (%)

A disproportionately
large placenta
relative to birth
weight was
associated with
increased risk of
cardiovascular
disease death.

Birthweght:placental
weight.

BW/PW ratio
significantly greater
in boys. No
significance found in
neonatal
measurements and
SBP.

Study focused
on BW and SBP,
PW and BW:PW
ratio were only
considered in a
regression
model.

Whincup, Bredow,
Payne, Sadler.
Golding and the
ALSPAC Study
Team (1999) Size
at birth and blood
pressure at 3
years of Age The
Avon Longitudinal
study of
Pregnancy and
Childhood
(ALSPAC) Am J
Epidemiol
149(8):730-739
Barker (1997)
Fetal nutrition
and
cardiovascular
disease in later
life British Medical
Bulletin 53(1):96108

Blake, Gurrin,
Beilin, Stanley,
Landau &
Newnham. (2001)
Placental weight
and placental
ration as
predictors of later
blood pressure in
childhood Journal
of Hypertension
19:697-702

Avon, England
1991-1992

Summary article
containing data
from Preston
cohort

Avon, Southwest
Regional Health
Authority 10%
random sample
from June 6 to
December 11,
1992.

N/A

King Edward
Memorial
Hospital, Perth,
Raine Cohort 1989- Western
1992
Australia.

Historic Medical
Records and
longitudinal study
with follow up
every 4 months
for first year and
the every 6
months.
Regression
coefficient and SE
with p-value for
trend

SBP and DBP

Mean SBP

Prospective
cohort study
mean BP with
95% CI

3

660 Not used

46-54 years

Systolic Blood
Pressure age 1, 3
and 6 yr.

Follow up at 1,
3 and 6 years
100

Age 1 - 964
Age 2 - 869
Age 3 - 1039

≤0.54kg
0.64kg
>0.64kg

Placental
weight/Birth weight
ratio

Placental weight
showed to have a
weak inverse relation
with blood pressure.
Which disappeared
after inclusion of
birth weight.
Placental ratio also
showed no relation
with blood pressure

At any given birth
weight, SBP rose as
placental weight
increased.
Inverse relationships
existed between both
systolic and diastolic
blood pressure and
placental weight,
adjusted for current
weight at ages 1, 3
and 6 years. The
relationships
between placental
weight and systolic
blood pressure were
statistically
significant at ages 1
and 3 years. There
was no consistent
relationship between
placental weight and
later blood pressure
within birth weight
categories. No
clinically or
statistically
significant
association was seen
between the

No data
supplied only
regression
coefficients.
Placenta were
fixed in
formalin prior
to weighing.

Sacrificing fetal
growth for
placental
growth.

placental ratio and
either systolic or
diastolic blood
pressures at any age.

Law, Barker, Bull
& Osmond. (1991)
Maternal and
fetal influences on
blood pressure
Archives of
Disease in
Childhood
66:1291-1295

Salisbury Health
District, UK. 198485

Hospital births in
Salisbury Health
District

Historical Medical
Records. Mean
Difference (95%
CI)

BP

4 yr

405

101

≤0.55kg
0.65kg
0.75kg
>0.75kg None reported

BP rose with
placental weight.
Children whose
placental weights
were greater than
750g, had average
pressures of 2.6mm
Hg (95% CI -0.8 to
6.0) above those
whose placental
weights were 550g or
less.

Barker, Bull,
Osmond &
Simmonds.
(1990)Fetal and
placental size and
risk of
hypertension in
adult life BMJ
301:259-62
Moore, Miller,
Boulton,
Cockington, Craig,
Magarey &
Robinson. (1996)
Placental weight,
birth
measurements,
and blood
pressure at age 8
years. Archives of
Disease in
Childhood
1996,74:538-541.
Moore,
Cockington, Ryan
& Robinson.
(1999) The
relationship
between birth
weight and blood
pressure amplifies
from childhood to
adulthood.
Journal of
Hypertension
17:883-888

Preston,
Lancashire, UK.
1935-43

Sharoe Green
Hospital Preston,
Lancashire.

Historical Medical
Records. Mean
Difference (95%
CI)

BP and treatment
for hypertension.

46-54 yr

In Pounds
(lb)
≤1.0
1.25
1.5
>1.5
Converted to
kg
≤0.45kg
0.57
0.68
>0.68 None reported

449(124)

Adelaide, South
Australia. 1975-76

Queen Victoria
Hospital,
Adelaide, South
Australia

Historical Medical
Records Mean SD

BP

8 yr.

830

Follow up of
Adelaide cohort

Queen Victoria
Hospital,
Adelaide, South
Australia

Longitudinal
study correlation
r

SBP DBP

20 years

584

102

≤500g
501-600g
>600g

None reported

The highest pressures
were among people
who had been small
babies with large
placentae and the
lowest were among
people who had been
large babies with
small placentae.

Placental weight
alone was not related
to systolic BP. There
was a positive but
not statistically
significant
relationship between
placental weight and
diastolic BP.
Placental weight
alone was not related
to systolic BP. A
positive association
with the ratio of
placental weight to
birth weight was
seen, this was
diminished on
adjustment for
gestational age.
Correlation with
placental weight was
seen but did not
persist after

Systolic and
diastolic blood
pressures were
strongly related
to placental
weight.

At any birth
weight BP
tended to rise
with increasing
placental
weight. At any
placental
weight BP
tended to fall
with increasing
birth weight.

adjustment for
gestational age.

Forrester, Wilks,
Bennett, Simeon,
Osmond, Allen,
Ching & Scott
(1996) Fetal
growth and
cardiovascular risk
factors in
Jamaican
schoolchildren
BMJ 312:156-160

Forsen, Eriksson,
Tuomilehto,
Osmond & Barker.
(1999) Growth inutero and during
childhood among
women who
develop coronary
heart disease:
longitudinal study.
BMJ
1999;319:1403-7
Forsen, Eriksson,
Tuomilehto,
Teramo, Osmond
& Barker. (1997)
Mother's weight
in pregnancy and
coronary heart
disease in a
cohort of Finnish
men: follow up

Kingston, Jamaica,
West Indies nd.

University
Hospital of the
West Indies,
Kingston,
Jamaica. 27
surrounding
schools.

Helsinki, Finland
1924-33 Women

Helsinki
University Central
Hospital, Finland.

Helsinki, Finland
1924-33 Men

Helsinki
University Central
Hospital, Finland.

Historical Medical
Records and
follow up

Historic Medical
Records HR

Historic Medical
Records SMR

SBP

6-16 years

Hospital admission
for or death from
coronary heart
disease.

Not reported

Death by ICD code
8 or 9

mean age of
death 57 years
(range 37-70)
103

1610 Not reported

500g
600g
700g
3447 >700g

500g
600g
700g
3302(286) >700g

None reported

Placental
weight/Birth weight
ratio

None reported

Placental weight was
inversely related to
systolic pressure
after adjustment for
age, sex, and current
weight (test for trend
p=0.003) There was
no significant relation
between the ratio of
placental to birth
weights and blood
pressure.
Hazard ratios tended
to rise with
increasing placental
weight although this
trend was not
significant.
There was a
significant rise with
an increasing ratio of
placental weight to
birth weight (P=0.01,
adjusted for
gestation)
Trends for fatal and
non-fatal disease
were similar.
Ponderal index was
strongly related to
placental weight,
mean with low
placental weight had
low ponderal index at
birth and raised
death rates from
coronary heart
disease as adults.

No data on
placenta
reported. Only
defining
statement.

HR trends seen
in simultaneous
analysis
between
placental
weight, birth
length, birth
weight,
gestational age.

placental
weight not
investigated
directly.

study BMJ
315:837-40

Eriksson, Forsen,
Tuomilehto,
Osmond & Barker.
(2000) Fetal and
Childhood Growth
and Hypertension
in Adult Life
Hypertension
36:790-794
Taylor, Whincup,
Cook, Papacosta
& Walker (1997)
Size at birth and
blood pressure:
cross sectional
study in 8-11 year
old children. BMJ
1997;314:475
Whincup, Cook,
Papacosta &
Walker (1995)
Birth weight and
blood pressure:
cross sectional
and longitudinal
relations in
childhood. BMJ
311:773

Helsinki, Finland
1924-1933 still
resident in Helsinki
in 1971

10 towns across in
England and Wales

Guildford and
Carlisle 1987 &
1991

Helsinki
University Central
Hospital, Finland.

Historic Medical
Records p value
for trend
cumulative
incidence (%)

School based

Cross sectional
survey Linear
regression model

School based

Cross sectional
survey Regression
coefficient and SE

Registered use of
medication for
hypertension

SBP DBP

Not reported

8-11 years

≤450g
550g
650g
750g
7086(1958) >750g

3010 Not used

Low ≤589g
Mid 590689g
1511 High ≥670g

BP

104

Placental
weight/Birth weight
ratio

No significant trend
with either placental
weight or the ratio of
placental weight to
birth weight. From
men and women
with both
hypertension and
NIDDM, cumulative
incidence fell with
increasing placental
weight. Children with
both had small
placental size as well
as small body size at
birth.

Placental
weight/Birth weight
ratio

The association
between placental
weight and placental
ratio and blood
pressure in children
8-11 years is
inconsistent

Regression
coefficients (b)
reported

Placental ratio and
placental weight is
not related to blood
pressure in children

Birth weight
was based on
maternal recall.

Campbell, Hall,
Barker, Cross,
Shiell and
Godfrey. (1996)
Diet in pregnancy
and the
offspring's blood
pressure 40 years
later. British
Journal of
Obstetrics and
Gynaecology
103:273-280

Fan, Zhang, Li,
Wang, Xu, Gong,
Zhou, Wen &
Zeng. (2009)
Relationship
between birth size
and coronary
heart disease in
China. Annals of
Medicine 42(8):
596-602

Aberdeen,
Scotland. 1948-54

Beijing, China.
1921-1954

Aberdeen
Maternity
Hospital

Peking Union
Medical College
Hospital

Historic Medical
Records.
Longitudinal
Regression
Coefficient and
95% CI

Historic Medical
Records.
Retrospective
randomly
selected subcohort. Odds ratio
95%CI

SBP DBP
Rose/WHO Chest
Pain Questionnaire
12-lead ECG
Defined CHD by
the presence of 1
or more of the
following: typical
angina (according
to the
questionnaire);
ECG Minnesota
codes 1-1, 1-2 (Q
and QS codes);
more than 50%
coronary artery
stenosis on
angiography, or a
history of coronary
artery
revascularisation,
either coronary bypass graft or
coronary
angioplasty; or
non-fatal
myocardial
infarction; further
ECG changes or
raised cardiac
enzyme activities.

Mean age 40.6
yr

105

Diet was
determined by
a survey and
follow was
made 40 years
later to
measure BP

≤450g
450 - 560g
560 - 670g
≥675g None reported

Prevalence of CHD
was inversely
associated with
placental weight (P <
0.05)
Placental weights
were low with 17.8%
of all placenta
weighing less than
450g
Mean placental
weight (male) 539.6 ±
103.1 g; Mean
placental weight
(female) 525.7 ±
101.8 g

Birth weights
were especially
low, 8% of
births were less
than 2500g.

253 Not used

Mean age
(men) 59.9 ±

8.4 years
Mean age
(women) 59.9 ±
8.1 years

None reported

Placental weight was
positively correlated
with mother's weight
(r=0.17) Low
placental weight was
associated with a
higher blood
pressure in the
offspring though this
was not statistically
significant (r=-9.2
mmHg/kg; 95% CI 22.6 - 41.; P=0.2

2033 (135)

Martyn, Barker &
Osmond (1996)
Mother's pelvic
size, fetal growth,
and death from
stroke and
coronary heart
disease in men in
the UK The Lancet
348:1264-68
Barker, Godfrey,
Osmond & Bull
(1992) The
relation of fetal
length, ponderal
index and head
circumference to
blood pressure
and the risk of
hypertension in
adult life.
Paediatric and
Perinatal
Epidemiology6:3544

Hertfordshire and
Sheffield, UK.
1907-1930

Preston, England
1935-1943

Eriksson, Kajantie,
Osmond,
Thornburg &
Barker (2010)
Boys live
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9. Appendix B NOS Quality Assessment Form for Cohort
Studies.
Note: A study can be given a maximum of one star for each numbered item within the Selection
and Outcome categories. A maximum of two stars can be given for Comparability.

Selection
1) Representativeness of the exposed cohort
a)
b)
c)
d)

Truly representative (one star)
Somewhat representative (one star)
Selected group
No description of the derivation of the cohort

2) Selection of the non-exposed cohort
a)
b)
c)

Drawn from the same community as the exposed cohort (one star)
Drawn from a different source
No description of the derivation of the non-exposed cohort

3) Ascertainment of exposure
a)
b)
c)
d)
e)

Secure record (e.g., surgical record) (one star)
Structured interview (one star)
Written self-report
No description
Other

4) Demonstration that outcome of interest was not present at start of study a) Yes (one star)
b) No

Comparability
1) Comparability of cohorts on the basis of the design or analysis controlled for confounders
a)
The study controls for age, sex and marital status (one star)
b)
Study controls for other factors (list) _________________________________
(one star)
c)
Cohorts are not comparable on the basis of the design or analysis controlled for
confounders

Outcome
1) Assessment of outcome
a)
b)
c)
d)
e)

Independent blind assessment (one star)
Record linkage (one star)
Self-report
No description
Other

2) Was follow-up long enough for outcomes to occur
a) Yes (one star)
b) No
Indicate the median duration of follow-up and a brief rationale for the assessment
above:____________________
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3) Adequacy of follow-up of cohorts
a) Complete follow up- all subject accounted for (one star)
b) Subjects lost to follow up unlikely to introduce bias- number lost less than or equal to
20% or description of those lost suggested no different from those followed. (one star)
c) Follow up rate less than 80% and no description of those lost
d) No statement

E-17
Thresholds for converting the Newcastle-Ottawa scales to AHRQ
standards (good, fair, and poor):
Good quality: 3 or 4 stars in selection domain AND 1 or 2 stars in
comparability domain AND 2 or 3 stars in outcome/exposure domain
Fair quality: 2 stars in selection domain AND 1 or 2 stars in
comparability domain AND 2 or 3 stars in outcome/exposure domain
Poor quality: 0 or 1 star in selection domain OR 0 stars in comparability domain OR
0 or 1 stars in outcome/exposure domain
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